RxNorm Semantic Concepts Index - 131
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "131".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1310000 | Picea abies flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310001 | Hieracium pilosella flowering top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310002 | Hippomane mancinella fruiting leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310003 | Viscum album leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310004 | Prunus persica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310005 | Plantago major leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310006 | Bromus ramosus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310007 | Aralia hispida root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310008 | Hibiscus rosa-sinensis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310009 | Prunus persica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310011 | Rosa moschata seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310013 | Dalbergia pinnata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310014 | Mandragora officinarum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310015 | Ruehssia cundurango bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310015 | Ruehssia cundurango bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310016 | Rosa damascena flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310017 | Prunus laurocerasus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310018 | Anamirta cocculus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310019 | Prunus persica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310021 | Crataegus monogyna flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310022 | Styphnolobium japonicum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310023 | Vincetoxicum hirundinaria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310023 | Vincetoxicum hirundinaria leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310024 | Comocladia dentata bark-leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310025 | Castanea sative leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310027 | camphor 0.031 MG/MG / menthol 0.16 MG/MG / methyl salicylate 0.1 MG/MG [Flexall Ultra Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310029 | Senna alexandrina seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310030 | Spanish thyme oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310031 | Nerium oleander leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310032 | Turnera diffusa leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310033 | Pimpinella saxifraga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310034 | Magnolia liliiflora flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310035 | Solanum dulcamara stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310036 | Tsuga canadensis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310037 | Prunus serrulata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310038 | lactose, x-ray exposed (1000 rad) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310039 | Trifolium pratense flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310040 | millet extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310041 | Citrus junos seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310042 | Toxicodendron diversilobum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310043 | Cicuta virosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310044 | cashew oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310045 | Larix decidua flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310046 | sesame seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310047 | Nelumbo nucifera flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310048 | Helichrysum italicum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310049 | Peumus boldus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310050 | Stillingia sylvatica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310051 | Solanum dulcamara flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310052 | Nymphaea odorata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310055 | Morus alba root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310056 | Jacaranda caroba flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310057 | Teucrium scorodonia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310058 | Reversion Acne Control Toner | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310059 | salicylic acid 20 MG/ML [Reversion Acne Control Toner] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310060 | salicylic acid Topical Solution [Reversion Acne Control Toner] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310061 | Reversion Acne Control Toner Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310063 | Frangula alnus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310064 | Citrus sinensis fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310065 | Rheum officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310066 | Matricaria chamomilla leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310066 | Matricaria chamomilla leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310067 | Punica granatum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310068 | Trichosanthes cucumerina seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310069 | Hypoxis hemerocallidea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310070 | European white birch tar oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310070 | European white birch tar oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310071 | Aconitum carmichaelii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310072 | Cuscuta chinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310073 | Salix alba flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310075 | Dipsacus asper root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310076 | Calabar bean seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310076 | Calabar bean seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310078 | Justicia gendarussa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310079 | Lespedeza capitata flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310080 | Plantago major seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310081 | Pilocarpus jaborandi leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310082 | Trichosanthes kirilowii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310083 | Eleutherococcus nodiflorus root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310084 | Pinus sylvestris flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310085 | Entada phaseoloides leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310087 | Polygala senega root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310088 | Rhaphiolepis bibas leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310088 | Rhaphiolepis bibas leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310091 | Syzygium cumini seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310092 | Hippophae rhamnoides fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310093 | Haberlea rhodopensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310094 | Lophatherum gracile leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310095 | Pinus sylvestris leafy twig | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310096 | Rubus chamaemorus seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310097 | lovage oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310098 | galanga root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310098 | galanga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310099 | Podophyllum peltatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310100 | Populus tremula flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310101 | Paeonia officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310102 | redtop top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310102 | redtop top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310102 | redtop top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310103 | Trillium erectum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310105 | Citrus bergamia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310106 | Populus tremuloides bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310107 | Pinus densiflora bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310108 | Populus tremuloides leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310110 | Scleranthus annuus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310111 | Amanita muscaria var. muscaria fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310112 | Sempervivum tectorum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310113 | Paulownia tomentosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310114 | Balanites roxburghii seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310115 | ornithogalum umbellatum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310117 | Citrus aurantiifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310119 | Myosotis sylvatica flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310120 | Berberis vulgaris root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310121 | cesium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310122 | chlorine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310123 | F - Fluorine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310123 | F - Fluorine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310123 | F - Fluorine | Designated preferred name (PT) | NO | |
| RxCUI: 1310123 | F - Fluorine | Full form of descriptor (FN) | NO | |
| RxCUI: 1310123 | F - Fluorine | Designated preferred name (PT) | NO | |
| RxCUI: 1310123 | F - Fluorine | Full form of descriptor (FN) | NO | |
| RxCUI: 1310124 | gallium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310126 | Bacopa monniera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310127 | Citrus paradisi fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310129 | dimethicone Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310131 | Viscum album fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310133 | Onosmodium virginianum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310134 | Elymus repens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310137 | Afinitor Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310140 | Glechoma hederacea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310141 | Epimedium grandiflorum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310148 | Wyethia helenioides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310150 | Papaver rhoeas flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310151 | Symphytum tuberosum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310152 | Dactylis glomerata top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310154 | Syzygium jambos seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310155 | Zanthoxylum americanum bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310157 | Jateorhiza calumba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310159 | Juglans regia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310161 | Juniperus sabina leaf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310162 | Chrysanthellum indicum subsp. afroamericanum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310163 | Kalmia angustifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310164 | Centella asiatica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310164 | Centella asiatica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310164 | Centella asiatica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310166 | Pelargonium sidoides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310167 | Handroanthus impetiginosus bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310167 | Handroanthus impetiginosus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310168 | quassia | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310168 | quassia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310171 | gadolinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310173 | Rhus glabra top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310179 | Vicodin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310183 | curly dock top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310183 | curly dock top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310185 | strychnine nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310187 | Lithium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310187 | Lithium bromide | Designated preferred name (PT) | NO | |
| RxCUI: 1310187 | Lithium bromide | Full form of descriptor (FN) | NO | |
| RxCUI: 1310189 | Juniperus communis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131019 | 11-oxopregnanetriol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131019 | 11-oxopregnanetriol | Designated preferred name (PT) | NO | |
| RxCUI: 131019 | 11-oxopregnanetriol | Full form of descriptor (FN) | NO | |
| RxCUI: 1310190 | Ammonium carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310190 | Ammonium carbonate | Designated preferred name (PT) | YES | |
| RxCUI: 1310190 | Ammonium carbonate | Full form of descriptor (FN) | YES | |
| RxCUI: 1310193 | mercurius solubilis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310197 | acetaminophen 300 MG / hydrocodone bitartrate 5 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310197 | acetaminophen 300 MG / hydrocodone bitartrate 5 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Designated preferred name (PT) | NO | |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Full form of descriptor (FN) | NO | |
| RxCUI: 1310200 | Vicodin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310203 | Rhododendron tomentosum leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310203 | Rhododendron tomentosum leafy twig extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310208 | acetaminophen 300 MG / hydrocodone bitartrate 7.5 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310208 | acetaminophen 300 MG / hydrocodone bitartrate 7.5 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310213 | American elderberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310215 | Ruta graveolens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310216 | black widow spider preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310217 | Solanum nigrum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310220 | Aconitum napellus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310220 | Aconitum napellus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310227 | Piper cubeba fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310229 | Ecballium elaterium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310235 | Spigelia anthelmia whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310235 | Spigelia anthelmia whole preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310238 | bovine achilles tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310238 | bovine achilles tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310241 | water 990 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310244 | bovine adrenal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310244 | bovine adrenal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310246 | bovine ankle joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310246 | bovine ankle joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310248 | Berberis vulgaris fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310249 | bovine bile preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310249 | bovine bile preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310249 | bovine bile preparation | Designated preferred name (PT) | NO | |
| RxCUI: 1310249 | bovine bile preparation | Full form of descriptor (FN) | NO | |
| RxCUI: 1310251 | bovine cartilage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310251 | bovine cartilage preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310252 | beryllium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310253 | bovine colostrum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310253 | bovine colostrum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310255 | bovine frontal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310255 | bovine frontal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310256 | bovine gallbladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310256 | bovine gallbladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310258 | bovine hip joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310258 | bovine hip joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310259 | Crataegus laevigata fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310260 | bovine hippocampus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310260 | bovine hippocampus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310261 | bovine hypothalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310261 | bovine hypothalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310262 | bovine knee joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310262 | bovine knee joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310263 | bovine limbic system preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310263 | bovine limbic system preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310264 | bovine lymph preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310264 | bovine lymph preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310265 | bovine mesenchyme preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310265 | bovine mesenchyme preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310266 | Anemone nemorosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310267 | bovine nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310267 | bovine nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310268 | acetaminophen 300 MG / hydrocodone bitartrate 10 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310268 | acetaminophen 300 MG / hydrocodone bitartrate 10 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310273 | bovine ovary preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310273 | bovine ovary preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310275 | bovine pancreas preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310275 | bovine pancreas preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310276 | Virola sebifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310279 | Polygonum aviculare top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310280 | Acorus calamus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310281 | Scomberomorus cavalla extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310282 | Trillium erectum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310285 | Gaultheria procumbens top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310287 | Luffa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310287 | Luffa extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310288 | Chaenomeles speciosa fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310289 | bovine parathyroid gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310289 | bovine parathyroid gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131029 | Actin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131029 | Actin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310290 | bovine pineal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310290 | bovine pineal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310291 | bovine pituitary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310291 | bovine pituitary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310292 | bovine erythrocyte preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310292 | bovine erythrocyte preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310293 | bovine solar plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310293 | bovine solar plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310294 | bovine spinal cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310294 | bovine spinal cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310295 | bovine spleen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310295 | bovine spleen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310296 | bovine sympathetic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310296 | bovine sympathetic nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310297 | bovine tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310297 | bovine tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310298 | bovine testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310298 | bovine testicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310299 | bovine tonsil preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310299 | bovine tonsil preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131030 | Actinomyces species antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131030 | Actinomyces species antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310300 | Co - Cobalt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310300 | Co - Cobalt | Designated preferred name (PT) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Full form of descriptor (FN) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Designated preferred name (PT) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Full form of descriptor (FN) | NO | |
| RxCUI: 1310339 | Cyclamen purpurascens tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310350 | Datura stramonium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310367 | Euphorbia resinifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131037 | Alpha lactalbumin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131037 | Alpha lactalbumin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131038 | Alpha>1< antichymotrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131038 | Alpha>1< antichymotrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131039 | Alpha>1< antitrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131039 | Alpha>1< antitrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310456 | Crotalus horridus horridus venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310457 | Heloderma horridum venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310458 | Lachesis muta venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310459 | Latrodectus mactans venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310459 | Latrodectus mactans venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310459 | Latrodectus mactans venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310459 | Latrodectus mactans venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310460 | Micrurus corallinus venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310461 | Naja naja venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310463 | calcium phosphate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310465 | calcium sulfate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310466 | calcium sulfate, hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310467 | creatine monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310469 | dehydrated alcohol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310470 | disodium edetate hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310472 | benzalkonium chloride 4.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310476 | Vetadryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310477 | diphenhydramine hydrochloride 10 MG [Vetadryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310477 | diphenhydramine hydrochloride 10 MG [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310478 | diphenhydrAMINE Oral Tablet [Vetadryl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310478 | diphenhydrAMINE Oral Tablet [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310479 | Vetadryl Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310480 | Vetadryl Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310482 | diphenhydramine hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310482 | diphenhydramine hydrochloride 30 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310484 | diphenhydramine hydrochloride 30 MG [Vetadryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310484 | diphenhydramine hydrochloride 30 MG [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1310495 | beta-citronellol, (R)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310496 | dimethicone 100 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310497 | povidone K90 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310499 | chlorpheniramine / ibuprofen / phenylephrine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310500 | chlorpheniramine / ibuprofen / phenylephrine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310501 | chlorpheniramine / ibuprofen / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310502 | chlorpheniramine / ibuprofen / phenylephrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1310503 | chlorpheniramine maleate 4 MG / ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310503 | chlorpheniramine maleate 4 MG / ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 131051 | Amyloid P component antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131051 | Amyloid P component antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310510 | bisoctrizole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310511 | high fructose corn syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310512 | maltose syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310513 | sorbitan isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310514 | lactoperoxidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310517 | anchovy preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310519 | Limonia acidissima wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131052 | Prealbumin amyloid antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131052 | Prealbumin amyloid antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310520 | teriflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1310520 | teriflunomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310520 | teriflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 1310520 | teriflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1310520 | teriflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 1310521 | teriflunomide 14 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310522 | teriflunomide Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1310522 | teriflunomide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310522 | teriflunomide Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1310523 | teriflunomide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310524 | teriflunomide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310526 | Aubagio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1310527 | teriflunomide 14 MG [Aubagio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310528 | teriflunomide Oral Tablet [Aubagio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310529 | Aubagio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Designated preferred name (PT) | NO | |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Full form of descriptor (FN) | NO | |
| RxCUI: 1310530 | Aubagio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310532 | teriflunomide 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310534 | teriflunomide 7 MG [Aubagio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310536 | sodium polyacrylate (2500000 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310537 | undecyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310538 | trihydroxystearin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310539 | di(4-tert-butylcyclohexyl) peroxydicarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310540 | acetylcarnitine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310541 | D&C red no. 21 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310542 | butylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310542 | butylene glycol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310543 | 1,3-dimethylol-5,5-dimethylhydantoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310544 | aminomethylpropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310544 | aminomethylpropanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Designated preferred name (PT) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | Full form of descriptor (FN) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | Designated preferred name (PT) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Full form of descriptor (FN) | YES | |
| RxCUI: 1310546 | acesulfame | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310548 | alkyl (C12-15) benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310549 | trisodium citrate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310550 | butane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310551 | Stearic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310551 | Stearic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1310551 | Stearic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1310551 | Stearic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1310551 | Stearic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1310551 | Stearic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310551 | Stearic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310553 | zinc stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310554 | triethyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310555 | stearalkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310557 | methylparaben sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310558 | FD & C red no. 40 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310559 | D&C red no. 27 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310562 | FD &C yellow #6 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310563 | D & C red # 30 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310564 | D&C red no. 7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310565 | ethylcellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310565 | ethylcellulose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310566 | magnesium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310567 | magnesium stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310568 | methyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310568 | methyl alcohol | Designated preferred name (PT) | YES | |
| RxCUI: 1310568 | methyl alcohol | Full form of descriptor (FN) | YES | |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310569 | sodium laureth-3 sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310569 | sodium laureth-3 sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310570 | laureth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310571 | shea butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310572 | ferric oxide red | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310572 | ferric oxide red | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310573 | croscarmellose sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310574 | croscarmellose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310575 | FD&C red no. 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310576 | corn syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Designated preferred name (PT) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Full form of descriptor (FN) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Designated preferred name (PT) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Full form of descriptor (FN) | YES | |
| RxCUI: 1310579 | butyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310580 | methyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310581 | menthyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310582 | hydrogenated palm glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310583 | methylcellulose (100 CPS) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310584 | Laminaria digitata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310585 | phenyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310586 | octyltriethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310587 | skim milk | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310588 | {10 (12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet) / 10 (12 HR clonidine hydrochloride 0.2 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310588 | {10 (12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet) / 10 (12 HR clonidine hydrochloride 0.2 MG Extended Release Oral Tablet) } Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310593 | D&C red no. 22 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310593 | D&C red no. 22 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310593 | D&C red no. 22 | Designated preferred name (PT) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310593 | D&C red no. 22 | Designated preferred name (PT) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310594 | Macrogol 4000 | Designated preferred name (PT) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Designated preferred name (PT) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310598 | polyethylene glycol 600 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310599 | carbomer copolymer type A (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310599 | carbomer copolymer type A (allyl pentaerythritol crosslinked) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310600 | Allura red AC dye | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310601 | D.C. red no. 33 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310602 | diazolidinylurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310603 | oleyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310605 | brilliant blue FCF | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310635 | Osteo Bi-Flex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310636 | chondroitin sulfates 200 MG / glucosamine hydrochloride 250 MG [Osteo Bi-Flex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310637 | chondroitin sulfates / glucosamine Oral Tablet [Osteo Bi-Flex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310638 | Osteo Bi-Flex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310639 | Osteo Bi-Flex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310641 | Rhulicort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310642 | hydrocortisone acetate 5 MG/ML [Rhulicort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310643 | hydrocortisone Topical Cream [Rhulicort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310644 | Rhulicort Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310647 | apple pectin 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310648 | apple pectin / Lactobacillus acidophilus Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310653 | Lactobacillus rhamnosus GG 1.5 Billion Cells Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310653 | Lactobacillus rhamnosus GG 1.5 Billion Cells Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Full form of descriptor (FN) | NO | |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Designated preferred name (PT) | NO | |
| RxCUI: 131067 | Aureobasidium pullulans antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131067 | Aureobasidium pullulans antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131070 | B lymphocyte antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131070 | B lymphocyte antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310705 | fast green FCF stain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310706 | crospovidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310707 | D&C red no. 28 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310708 | ferrosoferric oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310709 | ceteth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310713 | Tri-zel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310714 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [Tri-zel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310715 | azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide Oral Tablet [Tri-zel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310716 | Tri-zel Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310717 | Tri-zel Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310751 | witch hazel 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310753 | inulin 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310816 | RevitaDERM Wound Care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1310817 | benzalkonium chloride 0.001 MG/MG [RevitaDERM Wound Care] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310818 | benzalkonium Topical Gel [RevitaDERM Wound Care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310819 | RevitaDERM Wound Care Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310822 | dimethicone 24.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310826 | dimethicone 10.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310844 | Bacillus coagulans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310844 | Bacillus coagulans | Designated preferred name (PT) | YES | |
| RxCUI: 1310844 | Bacillus coagulans | Full form of descriptor (FN) | YES | |
| RxCUI: 1310845 | Lactobacillus helveticus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310846 | Proteus inconstans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310848 | Aphanizomenon flos-aquae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310903 | Proteus mirabilis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310905 | Trichophyton verrucosum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310907 | Mycobacterium phlei | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310908 | Brevibacterium stationis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310909 | Propionibacterium avidum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310910 | Propionibacterium acnes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310913 | Pseudomonas aeruginosa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310914 | Candida parapsilosis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310923 | Butorphic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310924 | butorphanol 10 MG/ML [Butorphic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310925 | butorphanol Injectable Solution [Butorphic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310926 | Butorphic Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131093 | Extended-spectrum beta lactamase | Designated preferred name (PT) | NO | |
| RxCUI: 131093 | Extended-spectrum beta lactamase | Full form of descriptor (FN) | NO | |
| RxCUI: 1310930 | {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310932 | glycerin Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1310933 | glycerin Medicated Bar Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 131094 | Beta-2-microglobulin amyloid antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131094 | Beta-2-microglobulin amyloid antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310942 | {30 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 30 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310944 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310945 | {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310946 | RhinaClear Dose Pack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310946 | RhinaClear Dose Pack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310950 | calcium carbonate 1500 MG / cholecalciferol 800 UNT [Caltrate Plus D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310951 | calcium carbonate / cholecalciferol Oral Tablet [Caltrate Plus D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 131100 | Bordetella parapertussis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131100 | Bordetella parapertussis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1311039 | Amanita muscaria extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311040 | brown rice preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311041 | Calvatia gigantea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311044 | Epimedium grandiflorum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311047 | immature Juglans regia fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311050 | Oenanthe aquatica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311051 | Picea mariana resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311052 | Quercus robur nut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311054 | tansy top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311054 | tansy top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311056 | causticum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311057 | Lycopodium clavatum spore extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311058 | brucine sulfate heptahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311059 | brucine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311060 | Mucuna pruriens fruit trichome extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311061 | Klebsiella pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311062 | oyster shell calcium carbonate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311063 | giant puffball extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311064 | barium chloride, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311065 | barium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311066 | Spongia officinalis skeleton extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311067 | Ba - Barium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311067 | Ba - Barium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311067 | Ba - Barium | Designated preferred name (PT) | NO | |
| RxCUI: 1311067 | Ba - Barium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311067 | Ba - Barium | Designated preferred name (PT) | NO | |
| RxCUI: 1311067 | Ba - Barium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311069 | pork brain preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311070 | Lanthanum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311070 | Lanthanum | Designated preferred name (PT) | NO | |
| RxCUI: 1311070 | Lanthanum | Full form of descriptor (FN) | NO | |
| RxCUI: 1311070 | Lanthanum | Designated preferred name (PT) | NO | |
| RxCUI: 1311070 | Lanthanum | Full form of descriptor (FN) | NO | |
| RxCUI: 1311071 | pork liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311072 | barium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311073 | Cairina moshcata heart-liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311076 | radium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311077 | Claviceps purpurea sclerotium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311078 | porcine pineal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311078 | porcine pineal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311079 | Sanguinaria canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311079 | Sanguinaria canadensis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311080 | Formica rufa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311080 | Formica rufa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311081 | cadmium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311083 | rancid beef preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311084 | choline hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311085 | xanthine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311085 | xanthine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311085 | xanthine | Designated preferred name (PT) | NO | |
| RxCUI: 1311085 | xanthine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311085 | xanthine | Designated preferred name (PT) | NO | |
| RxCUI: 1311089 | Defibrotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311089 | Defibrotide | Designated preferred name (PT) | YES | |
| RxCUI: 1311089 | Defibrotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311089 | Defibrotide | Designated preferred name (PT) | YES | |
| RxCUI: 1311089 | Defibrotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311090 | barium oxalosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311091 | Theridion curassavicum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311092 | Momordica balsamina immature fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311095 | human papillomavirus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311096 | Viscum album fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311098 | Mercurous chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311098 | Mercurous chloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311098 | Mercurous chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311100 | Symphoricarpos albus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311101 | Sanicula europaea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311102 | Canis lupus familiaris milk preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311103 | ytterbium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311105 | samarium oxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311107 | neodymium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311109 | Spongia officinalis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311110 | Mercuric cyanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311110 | Mercuric cyanide | Designated preferred name (PT) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Designated preferred name (PT) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311112 | Bacillus cereus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311114 | lanthanum oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311116 | europium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311117 | mammal liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311118 | gadolinium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311119 | Bacillus subtilis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311121 | Pseudognaphalium obtusifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311121 | Pseudognaphalium obtusifolium whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311122 | Triticum aestivum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311123 | Sodium caprylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311123 | Sodium caprylate | Designated preferred name (PT) | YES | |
| RxCUI: 1311123 | Sodium caprylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311125 | Myrtus communis top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311127 | Ascophyllum nodosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311128 | Citharacanthus spinicrus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311129 | yeast mannan preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311130 | osmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311131 | iridium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311133 | Larrea tridenta top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311134 | Propyl gallate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311134 | Propyl gallate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311134 | Propyl gallate | Designated preferred name (PT) | YES | |
| RxCUI: 1311134 | Propyl gallate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311134 | Propyl gallate | Designated preferred name (PT) | YES | |
| RxCUI: 1311137 | acetaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311138 | Sodium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311138 | Sodium bromide | Designated preferred name (PT) | NO | |
| RxCUI: 1311138 | Sodium bromide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1311140 | Sorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311140 | Sorbate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311141 | Norsynephrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311141 | Norsynephrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311141 | Norsynephrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311141 | Norsynephrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311143 | aji pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311144 | Sepia officinalis juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311146 | piperine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311147 | diethylene glycol monoethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311148 | Lycopus virginicus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311148 | Lycopus virginicus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311149 | Naphthalin | Designated preferred name (PT) | NO | |
| RxCUI: 1311149 | Naphthalin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311149 | Naphthalin | Designated preferred name (PT) | NO | |
| RxCUI: 1311149 | Naphthalin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311151 | Pulex irritans preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311152 | Hyoscyamus niger extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311153 | dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311153 | dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311154 | Pulsatilla patens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311155 | glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311159 | lead iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311160 | behentrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311163 | carbomer copolymer type b (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311163 | carbomer copolymer type b (allyl pentaerythritol crosslinked) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311165 | glyceryl monostearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311167 | pork kidney preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311170 | beef kidney preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311171 | D&C green no. 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311171 | D&C green no. 5 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311172 | D & C red no. 27 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311176 | D&C red no. 30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311177 | gonorrheal urethral secretion human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311178 | D&C red no. 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311179 | isopropyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311186 | lauramidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311188 | Anemone pulsatilla extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311188 | Anemone pulsatilla extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311190 | Au - Gold | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311190 | Au - Gold | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311190 | Au - Gold | Designated preferred name (PT) | YES | |
| RxCUI: 1311190 | Au - Gold | Full form of descriptor (FN) | YES | |
| RxCUI: 1311190 | Au - Gold | Designated preferred name (PT) | YES | |
| RxCUI: 1311190 | Au - Gold | Full form of descriptor (FN) | YES | |
| RxCUI: 1311192 | bovine joint capsule preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311192 | bovine joint capsule preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311193 | Corallium rubrum exoskeleton preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311197 | Laricifomes officinalis fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311199 | porcine small intestine mucosa lymph follicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311199 | porcine small intestine mucosa lymph follicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311202 | Super Spot Remover | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311203 | salicylic acid 0.02 MG/MG [Super Spot Remover] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311204 | salicylic acid Topical Gel [Super Spot Remover] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311205 | Super Spot Remover Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311207 | porcine artery preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311207 | porcine artery preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311210 | porcine vein preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311210 | porcine vein preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311212 | porcine brainstem preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311212 | porcine brainstem preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Designated preferred name (PT) | NO | |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311215 | porcine brain preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311215 | porcine brain preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311216 | cupric acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311217 | Proclearz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311218 | tolnaftate 10 MG/ML [Proclearz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311219 | tolnaftate Topical Solution [Proclearz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311220 | Proclearz Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311223 | porcine thalamus lateral geniculate nucleus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311223 | porcine thalamus lateral geniculate nucleus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311224 | indole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311225 | IL-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311225 | IL-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311225 | IL-3 | Designated preferred name (PT) | NO | |
| RxCUI: 1311225 | IL-3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311225 | IL-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311226 | porcine bile duct preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311226 | porcine bile duct preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311228 | Morganella morganii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311229 | porcine ileum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311229 | porcine ileum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311230 | disodium hydrogen phosphate dehydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311232 | porcine oral mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311232 | porcine oral mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311234 | porcine gallbladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311234 | porcine gallbladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311235 | porcine adrenal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311235 | porcine adrenal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311236 | ethylenediamine tetra (methylene phosphonic acid) monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311238 | orotic acid monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311240 | porcine hypothalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311240 | porcine hypothalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311241 | porcine pituitary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311241 | porcine pituitary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311242 | porcine stomach preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311242 | porcine stomach preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311243 | silicic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311244 | porcine limbic system preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311244 | porcine limbic system preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311245 | porcine nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311245 | porcine nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311246 | daikon extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311246 | daikon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311247 | porcine ankle joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311247 | porcine ankle joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311248 | porcine cartilage preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311248 | porcine cartilage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311249 | porcine frontal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311249 | porcine frontal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311250 | porcine hip joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311250 | porcine hip joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311251 | porcine hippocampus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311251 | porcine hippocampus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311252 | porcine joint capsule preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311252 | porcine joint capsule preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311253 | porcine lymph preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311253 | porcine lymph preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311254 | porcine mesenchyme preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311254 | porcine mesenchyme preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311255 | porcine erythrocyte preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311255 | porcine erythrocyte preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311256 | porcine solar plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311256 | porcine solar plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311257 | porcine spinal cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311257 | porcine spinal cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311258 | porcine sympathetic nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311258 | porcine sympathetic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311259 | magnesium sulfate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311260 | maltose monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311261 | Maltose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311261 | Maltose | Designated preferred name (PT) | YES | |
| RxCUI: 1311261 | Maltose | Full form of descriptor (FN) | YES | |
| RxCUI: 1311262 | porcine tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311262 | porcine tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311263 | porcine thymus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311263 | porcine thymus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311264 | porcine tonsil preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311264 | porcine tonsil preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311265 | Cantharis preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311265 | Cantharis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311266 | porcine vagus nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311266 | porcine vagus nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311268 | porcine colon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311268 | porcine colon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311269 | porcine renal pelvis preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311269 | porcine renal pelvis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311271 | Guaiacum sanctum resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311272 | porcine blood preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311272 | porcine blood preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311273 | scandium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311274 | porcine bone preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311274 | porcine bone preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311275 | Staphylococcus aureus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311276 | porcine bone marrow preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311276 | porcine bone marrow preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311278 | mercurio sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311278 | mercurio sulfide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311279 | palladium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311280 | platinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311281 | Streptococcus pyogenes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311282 | zinc sulfate, heptahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311283 | mercurous iodide preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311285 | ersofermin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311287 | Thyrocalcitonin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311287 | Thyrocalcitonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311287 | Thyrocalcitonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311288 | Mephitis mephitis anal gland fluid preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Designated preferred name (PT) | NO | |
| RxCUI: 1311289 | Lactuca virosa whole extract | Full form of descriptor (FN) | NO | |
| RxCUI: 1311289 | Lactuca virosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131129 | Calcitonin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131129 | Calcitonin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311291 | Danio rerio egg preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311292 | chromium gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311293 | Ferrum phosphoricum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311293 | Ferrum phosphoricum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311294 | potassium carbonate 1 1/2 hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311295 | benzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311296 | ferrous iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311297 | gold trichloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311298 | sodium carbonate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311299 | IL-10 | Designated preferred name (PT) | NO | |
| RxCUI: 1311299 | IL-10 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311301 | porcine heart preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311302 | Ononis spinosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311302 | Ononis spinosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311304 | calcium hexafluorosilicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311305 | Taraxacum officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311307 | Peptostreptococcus anaerobius | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311308 | strontium carbonate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311309 | salsolinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311310 | Primula veris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311311 | sodium dihydrogen phosphate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311312 | sodium hypophosphite monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311313 | sodium hypophosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311314 | ferric picrate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311315 | porcine capillary tissue preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311315 | porcine capillary tissue preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311316 | porcine cerebellum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311316 | porcine cerebellum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311317 | porcine cerebral cortex preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311317 | porcine cerebral cortex preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311318 | Lonicera xylosteum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311319 | porcine collagen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311319 | porcine collagen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311319 | porcine collagen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 131132 | Campylobacter jejuni antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131132 | Campylobacter jejuni antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1311320 | porcine conjunctiva preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311320 | porcine conjunctiva preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311321 | porcine corpus luteum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311321 | porcine corpus luteum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311322 | porcine bronchus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311322 | porcine bronchus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311323 | sodium phosphate, dibasic, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311324 | porcine diencephalon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311324 | porcine diencephalon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311325 | porcine duodenum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311325 | porcine duodenum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311326 | sodium phosphate, dibasic, dodecahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311327 | porcine embryo preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311327 | porcine embryo preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311328 | porcine esophagus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311328 | porcine esophagus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311329 | porcine jejunum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311329 | porcine jejunum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311330 | porcine lung preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311330 | porcine lung preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311332 | porcine mammary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311332 | porcine mammary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311334 | porcine nasal mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311334 | porcine nasal mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311336 | porcine ovary preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311336 | porcine ovary preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311337 | porcine pancreas preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311337 | porcine pancreas preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311338 | porcine placenta preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311338 | porcine placenta preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311340 | porcine prostate preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311340 | porcine prostate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311341 | porcine pylorus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311341 | porcine pylorus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311342 | sodium phosphate, dibasic, monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311343 | porcine rectum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311343 | porcine rectum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311344 | porcine spleen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311344 | porcine spleen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311345 | sodium phosphate, tribasic, dodecahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311346 | porcine superior gastric plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311346 | porcine superior gastric plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311347 | porcine temporal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311347 | porcine temporal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311348 | porcine parathyroid gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311348 | porcine parathyroid gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311349 | porcine testicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311349 | porcine testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311350 | porcine thalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311350 | porcine thalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311354 | porcine tooth preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311354 | porcine tooth preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311355 | porcine umbilical cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311355 | porcine umbilical cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311356 | porcine ureter preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311356 | porcine ureter preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311357 | sodium phosphate, tribasic, monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311358 | porcine urethra preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311358 | porcine urethra preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311359 | porcine urinary bladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311359 | porcine urinary bladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311360 | porcine uterus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311360 | porcine uterus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311361 | porcine eye preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311361 | porcine eye preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311362 | sodium potassium tartrate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311363 | potassium sodium tartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311365 | porcine intervertebral disc preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311365 | porcine intervertebral disc preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311366 | porcine achilles tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311366 | porcine achilles tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311367 | porcine knee joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311367 | porcine knee joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311368 | Plantago major extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311369 | sodium succinate hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311370 | sodium succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311371 | stannous fluoride dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311372 | trehalose dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311373 | trehalose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311374 | Gardenia jasminoides fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311375 | kerosene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311376 | Chamaemelum nobile extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311377 | potassium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311378 | xylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311379 | sulfur iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311380 | IL-11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311380 | IL-11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311380 | IL-11 | Designated preferred name (PT) | NO | |
| RxCUI: 1311380 | IL-11 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311380 | IL-11 | Designated preferred name (PT) | NO | |
| RxCUI: 1311380 | IL-11 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311381 | toluene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311384 | tellurium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311385 | sinusitisinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311386 | 3-methylindole | Designated preferred name (PT) | NO | |
| RxCUI: 1311386 | 3-methylindole | Full form of descriptor (FN) | NO | |
| RxCUI: 1311387 | chlorogenic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311388 | holmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311389 | gallic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311390 | Santonin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311390 | Santonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311390 | Santonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311391 | nitric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311392 | porcine intestine preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311392 | porcine intestine preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311392 | porcine intestine preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311393 | amber | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311396 | magnesium ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311397 | caffeic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311398 | Lobelia | Designated preferred name (PT) | NO | |
| RxCUI: 1311398 | Lobelia | Full form of descriptor (FN) | NO | |
| RxCUI: 1311398 | Lobelia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311399 | Drimia maritima bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311402 | rhodium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311404 | Larix decidua resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311406 | Sorghum bicolor subsp. bicolor pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311406 | Sorghum bicolor subsp. bicolor pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311407 | Sb - Antimony | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311407 | Sb - Antimony | Designated preferred name (PT) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Full form of descriptor (FN) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Designated preferred name (PT) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Full form of descriptor (FN) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311410 | maitake extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311411 | Anemone americana extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311413 | chloroacetate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1311414 | chloroacetate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1311415 | chloroacetate 800 MG/ML Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311416 | Monocete | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311417 | chloroacetate 800 MG/ML [Monocete] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311418 | chloroacetate Medicated Pad [Monocete] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311419 | Monocete Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311420 | Monocete Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311475 | mercuric sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311476 | bromine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311477 | Chondrus crispus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311478 | carbon disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311479 | frankincense extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311480 | neodymium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311481 | praseodymium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311482 | dysprosium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311483 | erbium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311484 | europium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311485 | cetyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311488 | copovidone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311488 | copovidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311489 | rubidium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311490 | tantalum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311494 | ambergris | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311495 | sodium fluoride f-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311496 | thulium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311497 | Melissa officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311497 | Melissa officinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311498 | ytterbium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311499 | sea salt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311500 | mebrofenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311501 | Rosa canina fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Full form of descriptor (FN) | YES | |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311504 | Aluminum element | Designated preferred name (PT) | YES | |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Designated preferred name (PT) | YES | |
| RxCUI: 1311504 | Aluminum element | Full form of descriptor (FN) | YES | |
| RxCUI: 1311505 | ammonium glycyrrhizate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311505 | ammonium glycyrrhizate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Designated preferred name (PT) | NO | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Full form of descriptor (FN) | NO | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311508 | Origanum vulgare subsp. hirtum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311509 | Paullinia cupana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311510 | Petroselinum crispum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311511 | Peucedanum ostruthium leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311512 | Pfaffia paniculata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311516 | benzyl chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311517 | bismuth oxychloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311519 | carnitine chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311521 | Ceftiofur | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311521 | Ceftiofur | Designated preferred name (PT) | YES | |
| RxCUI: 1311521 | Ceftiofur | Full form of descriptor (FN) | YES | |
| RxCUI: 1311521 | Ceftiofur | Designated preferred name (PT) | YES | |
| RxCUI: 1311521 | Ceftiofur | Full form of descriptor (FN) | YES | |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311524 | Aspartamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311524 | Aspartamine | Designated preferred name (PT) | YES | |
| RxCUI: 1311524 | Aspartamine | Full form of descriptor (FN) | YES | |
| RxCUI: 1311524 | Aspartamine | Designated preferred name (PT) | YES | |
| RxCUI: 1311524 | Aspartamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311524 | Aspartamine | Full form of descriptor (FN) | YES | |
| RxCUI: 1311525 | cetrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311526 | calcium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 1311528 | cocamidopropyl propylene glycol-dimonium chloride phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311528 | cocamidopropyl propylene glycol-dimonium chloride phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311529 | Coffea arabica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311530 | ethanolamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311531 | European elderberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311532 | glycine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311533 | Lithium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311533 | Lithium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311533 | Lithium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311534 | tromethamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311537 | methylene chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311538 | Angelica keiskei top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311539 | magnesium chloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311540 | hexamethyldisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311541 | Aronia melanocarpa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311542 | Ornithine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311542 | Ornithine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311542 | Ornithine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311543 | Hibiscus sabdariffa calyx extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311544 | methylephedrine hydrochloride, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311545 | N-methylephedrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311545 | N-methylephedrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311545 | N-methylephedrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311546 | Hippophae rhamnoides fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311547 | Hordeum vulgare top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311548 | 4-hydroxyproline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311548 | 4-hydroxyproline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311548 | 4-hydroxyproline | Designated preferred name (PT) | YES | |
| RxCUI: 1311548 | 4-hydroxyproline | Full form of descriptor (FN) | YES | |
| RxCUI: 1311548 | 4-hydroxyproline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311549 | Aronia melanocarpa fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311550 | distearyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311551 | Lilium candidum bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311552 | distearyldimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311553 | robenidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311553 | robenidine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311553 | robenidine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311554 | robenidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311554 | robenidine | Designated preferred name (PT) | NO | |
| RxCUI: 1311554 | robenidine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311555 | nitarsone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311555 | nitarsone | Designated preferred name (PT) | NO | |
| RxCUI: 1311555 | nitarsone | Full form of descriptor (FN) | NO | |
| RxCUI: 1311556 | nonoxynol-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311557 | Benincasa hispida fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311558 | nonoxynol-100 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311559 | nonoxynol-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311560 | norflurane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311561 | holy basil top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311561 | holy basil top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311562 | Bidens bipinnata top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311563 | n-Pentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311563 | n-Pentane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311563 | n-Pentane | Designated preferred name (PT) | NO | |
| RxCUI: 1311563 | n-Pentane | Full form of descriptor (FN) | NO | |
| RxCUI: 1311564 | candelilla wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311565 | beta-propiolactone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311565 | beta-propiolactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311566 | Salinomycin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311566 | Salinomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311566 | Salinomycin | Designated preferred name (PT) | NO | |
| RxCUI: 1311566 | Salinomycin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311566 | Salinomycin | Designated preferred name (PT) | NO | |
| RxCUI: 1311567 | sulisobenzone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311568 | carnuba wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311569 | tetrofosmin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311570 | cetyl esters wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311571 | ethyl vanillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311572 | decyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Designated preferred name (PT) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311575 | C13-14 isoparaffin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Designated preferred name (PT) | YES | |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Full form of descriptor (FN) | YES | |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Full form of descriptor (FN) | YES | |
| RxCUI: 1311577 | Crataegus monogyna fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311579 | Tribulus terrestris fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311580 | Cullen corylifolium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311581 | Zanthoxylum piperitum fruit pulp extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311582 | nifurpipone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311583 | nicarbazin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311583 | nicarbazin | Designated preferred name (PT) | NO | |
| RxCUI: 1311583 | nicarbazin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311584 | Cymbopogon schoenanthus top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311585 | metomidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311586 | Pinus massoniana resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311588 | sodium glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311589 | Empetrum nigrum fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311590 | Forsythia suspensa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311591 | Fritillaria przewalskii bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311592 | benzododecinium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311593 | benzododecinium | Designated preferred name (PT) | NO | |
| RxCUI: 1311593 | benzododecinium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311593 | benzododecinium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311593 | benzododecinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311594 | Lauralkonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311594 | Lauralkonium bromide | Designated preferred name (PT) | YES | |
| RxCUI: 1311594 | Lauralkonium bromide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311594 | Lauralkonium bromide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311595 | Garcinia gummi-gutta fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311595 | Garcinia gummi-gutta fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311596 | Gleditsia sinensis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311597 | Lysozyme hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311597 | Lysozyme hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1311597 | Lysozyme hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1311598 | Hamamelis virginiana top water extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311599 | abetimus sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311600 | abetimus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311601 | Hedera helix top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311602 | 3,7-dimethyloctanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311603 | acetyltriethyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311604 | Hippophae rhamnoides fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311605 | Codium tomentosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311606 | amyl cinnamal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311608 | Hovenia dulcis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311609 | croscarmellose sodium type A | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311610 | chaga fruiting body extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311610 | chaga fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311611 | avocado oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311611 | avocado oil | Designated preferred name (PT) | YES | |
| RxCUI: 1311611 | avocado oil | Full form of descriptor (FN) | YES | |
| RxCUI: 1311612 | Ipomoea purpurea top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311613 | glycereth-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311614 | methyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311615 | Kigelia africana fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311616 | ethylhexyl methoxycrylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311617 | octyldodecyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311618 | lemon peel wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311619 | cetomacrogol 1000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311619 | cetomacrogol 1000 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311620 | ceteareth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311621 | ceteareth-15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311622 | ceteareth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311623 | ceteareth-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311624 | ceteareth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1311625 | magnesium sulfate anhydrous | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1311627 | Limonium vulgare flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311628 | cupric arsenite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311629 | nickel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311630 | lowbush blueberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311631 | strontium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311632 | Lycium barbarum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311633 | thallium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311634 | Bichloride of mercury | Designated preferred name (PT) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Designated preferred name (PT) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 1311635 | Lycium chinense fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311636 | Mahonia aquifolium fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311637 | anisacril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311638 | capryl methicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311639 | acetic monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311640 | tallow acid, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311641 | noni fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311641 | noni fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311642 | noni fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311642 | noni fruit juice | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311643 | Morus nigra fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311645 | Myrciaria dubia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311646 | Narcissus tazetta bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311647 | orange peel wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311648 | Panax ginseng fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311650 | ultramarine blue | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311651 | Passiflora incarnata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311653 | Perilla frutescens fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311654 | Phyllanthus emblica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311655 | hydrolyzed placental protein (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311656 | Phyllanthus niruri top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311658 | pomegranate fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311659 | bee propolis extact | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311659 | bee propolis extact | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1311661 | ammonium lactate 50 MG/ML [Geri-Hydrolac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311663 | Prunus mume fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311664 | Prunus serotina fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311665 | Brassica rapa var. rapa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311666 | Pyracantha fortuneana fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311667 | Rosa multiflora fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311668 | Rosa roxburghii fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311669 | pimagedine HCl | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311669 | pimagedine HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311670 | pimagedine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311671 | Rubus chamaemorus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311672 | indeloxazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311673 | indeloxazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311674 | Sapindus mukorossi fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311675 | Schisandra chinensis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311676 | ractopamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311677 | ractopamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311678 | glyceryl monooleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311678 | glyceryl monooleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311681 | Scutellaria lateriflora top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311682 | star anise fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311683 | Terminalia chebula fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311684 | Tetradium ruticarpum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311685 | Vaccinium myrtillus fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311686 | Vitex trifolia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311687 | Xanthium strumarium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311688 | Zanthoxylum armatum var. armatum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311689 | glycerol formal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311690 | glyceryl distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311691 | glyceryl dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311692 | glyceryl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311693 | glyceryl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311694 | glyceryl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311695 | glyceryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311743 | deslorelin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311744 | deslorelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311744 | deslorelin | Designated preferred name (PT) | YES | |
| RxCUI: 1311744 | deslorelin | Full form of descriptor (FN) | YES | |
| RxCUI: 1311745 | deslorelin 4.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311746 | deslorelin Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1311747 | deslorelin Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1311748 | deslorelin acetate 4.7 MG subcutaneous Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311748 | deslorelin acetate 4.7 MG subcutaneous Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311749 | Suprelorin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311750 | deslorelin 4.7 MG [Suprelorin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311751 | deslorelin Drug Implant [Suprelorin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311752 | Suprelorin Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131178 | Choriogonadotrophin antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131178 | Choriogonadotrophin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131178 | Choriogonadotrophin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311787 | Zostrix Cold Therapy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311788 | menthol 40 MG/ML [Zostrix Cold Therapy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311789 | menthol Topical Cream [Zostrix Cold Therapy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 131179 | Chromogranin A antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131179 | Chromogranin A antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311790 | Zostrix Cold Therapy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311792 | chloroxylenol 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311794 | Hooflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311795 | chloroxylenol 0.015 MG/MG [Hooflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311796 | chloroxylenol Topical Ointment [Hooflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311797 | Hooflex Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 131180 | Chromogranin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131180 | Chromogranin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311800 | chloroxylenol 15 MG/ML [Hooflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311801 | chloroxylenol Topical Solution [Hooflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311803 | witch hazel 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311807 | capsaicin 0.033 % Topical Cream (28.3 GM) / menthol 4 % Topical Cream (28.3 GM) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1311807 | capsaicin 0.033 % Topical Cream (28.3 GM) / menthol 4 % Topical Cream (28.3 GM) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311811 | alpha-hexylcinnamaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311817 | cultivated mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131182 | Chymotrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131182 | Chymotrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311820 | {10 (12 HR chlorpheniramine maleate 4 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) } Pack [RespiVent DF Dosepack 10] | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311824 | Allergy DN II Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311824 | Allergy DN II Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131185 | Clostridium difficile antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131185 | Clostridium difficile antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312084 | Yucca glauca root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312085 | Convallaria majalis bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312086 | TEA-lactate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312086 | TEA-lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131222 | Antigen of Cryptosporidium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131222 | Antigen of Cryptosporidium | Full form of descriptor (FN) | NO | |
| RxCUI: 131222 | Antigen of Cryptosporidium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131222 | Antigen of Cryptosporidium | Designated preferred name (PT) | NO | |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312261 | Derma Numb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312262 | lidocaine hydrochloride 40 MG/ML [Derma Numb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312263 | lidocaine Topical Spray [Derma Numb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312264 | Derma Numb Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312266 | Anthelban V | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312267 | pyrantel 50 MG/ML [Anthelban V] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312268 | pyrantel Oral Suspension [Anthelban V] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312269 | Anthelban V Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312270 | Anthelban V Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312271 | pyrantel 50 MG/ML Oral Suspension [Anthelban V] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312271 | pyrantel 50 MG/ML Oral Suspension [Anthelban V] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312274 | sulfadimethoxine 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312275 | sulfadimethoxine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312276 | sulfadimethoxine 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312277 | sulfadimethoxine 50 MG/ML [Albon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312278 | sulfadimethoxine Oral Suspension [Albon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312279 | Albon Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312357 | (C10-C30)alkyl methacrylate ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312358 | Aldosterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312358 | Aldosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312358 | Aldosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312358 | Aldosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312358 | Aldosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312359 | Androsterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312359 | Androsterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312359 | Androsterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312360 | C10-18 triglycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312361 | cetearyl isononanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312362 | chloromethyl methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312363 | chromium hydroxide green | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1312365 | Chrysanthellum indicum flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312366 | citric acid acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312367 | dehydroacetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312368 | trideceth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312369 | Tussilago farfara extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312370 | human sputum, Bordetella pertussis infected | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312371 | Thujopsis dolabrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312372 | Thujopsis dolabrata leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312373 | tetrasodium glutamate diacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312374 | salsolinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1312375 | influenza A virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312376 | influenza B virus whole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312376 | influenza B virus whole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312377 | Magnolia kobus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312378 | Rubus chamaemorus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312379 | Hexaplex trunculus hypobranchial gland juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312380 | Atropa belladonna fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312381 | phosphoramidic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312382 | Quercus rubra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312383 | Quercus alba extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312384 | measles virus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312385 | calcium behenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1312387 | dimethicone-diene dimethicone crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312388 | melanin synthetic (tyrosine, peroxide) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312389 | myristoyl tetrapeptide-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312390 | methyl methacrylate-glycol dimethacrylate crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312391 | glycereth-17 cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312392 | glyceryl monocaprylocaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312392 | glyceryl monocaprylocaprate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312394 | hydroxypropyl distarch phosphate, high amylose corn | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312395 | polyglyceryl-10 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312396 | PEG-9 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312397 | regorafenib | Full form of descriptor (FN) | YES | |
| RxCUI: 1312397 | regorafenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312397 | regorafenib | Designated preferred name (PT) | YES | |
| RxCUI: 1312397 | regorafenib | Full form of descriptor (FN) | YES | |
| RxCUI: 1312397 | regorafenib | Designated preferred name (PT) | YES | |
| RxCUI: 1312398 | regorafenib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1312399 | regorafenib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1312399 | regorafenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1312399 | regorafenib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 131240 | Du antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131240 | Du antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1312400 | regorafenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1312401 | regorafenib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1312402 | regorafenib 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1312402 | regorafenib 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312402 | regorafenib 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1312402 | regorafenib 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312403 | Stivarga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1312404 | regorafenib 40 MG [Stivarga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1312405 | regorafenib Oral Tablet [Stivarga] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1312406 | Stivarga Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1312407 | Stivarga Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1312408 | Stivarga 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1312408 | Stivarga 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312408 | Stivarga 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312409 | SITagliptin 50 MG / simvastatin 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312409 | SITagliptin 50 MG / simvastatin 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312409 | SITagliptin 50 MG / simvastatin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312409 | SITagliptin 50 MG / simvastatin 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312409 | SITagliptin 50 MG / simvastatin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131241 | Delta-5-pregnanetriol | Designated preferred name (PT) | NO | |
| RxCUI: 131241 | Delta-5-pregnanetriol | Full form of descriptor (FN) | NO | |
| RxCUI: 1312411 | simvastatin 10 MG / sitagliptin 50 MG [Juvisync] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312411 | simvastatin 10 MG / sitagliptin 50 MG [Juvisync] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312415 | Juvisync 50 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312416 | SITagliptin 50 MG / simvastatin 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312416 | SITagliptin 50 MG / simvastatin 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312416 | SITagliptin 50 MG / simvastatin 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312416 | SITagliptin 50 MG / simvastatin 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312416 | SITagliptin 50 MG / simvastatin 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312418 | simvastatin 20 MG / sitagliptin 50 MG [Juvisync] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312418 | simvastatin 20 MG / sitagliptin 50 MG [Juvisync] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 131242 | Dengue virus, type 1 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131242 | Dengue virus, type 1 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312422 | Juvisync 50 MG / 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312423 | SITagliptin 50 MG / simvastatin 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312423 | SITagliptin 50 MG / simvastatin 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312423 | SITagliptin 50 MG / simvastatin 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312423 | SITagliptin 50 MG / simvastatin 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312423 | SITagliptin 50 MG / simvastatin 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312425 | simvastatin 40 MG / sitagliptin 50 MG [Juvisync] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312425 | simvastatin 40 MG / sitagliptin 50 MG [Juvisync] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312429 | Juvisync 50 MG / 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 131243 | Dengue virus, type 2 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131243 | Dengue virus, type 2 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312430 | cephalexin 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312431 | cephalexin 150 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312431 | cephalexin 150 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312432 | Rilexine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312433 | cephalexin 150 MG [Rilexine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312434 | cephalexin Chewable Tablet [Rilexine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312435 | Rilexine Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312436 | Rilexine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312437 | Rilexine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312438 | Rilexine 150 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312438 | Rilexine 150 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312438 | Rilexine 150 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312439 | cephalexin 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 131244 | Dengue virus, type 3 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131244 | Dengue virus, type 3 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312440 | cephalexin 300 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312440 | cephalexin 300 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312441 | cephalexin 300 MG [Rilexine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312442 | Rilexine 300 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312442 | Rilexine 300 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312442 | Rilexine 300 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312443 | cephalexin 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312444 | cephalexin 600 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312444 | cephalexin 600 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312445 | cephalexin 600 MG [Rilexine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312446 | Rilexine 600 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312446 | Rilexine 600 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312446 | Rilexine 600 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312447 | capsaicin 0.00035 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 131245 | Dengue virus, type 4 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131245 | Dengue virus, type 4 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312451 | petrolatum 0.317 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312452 | petrolatum 31.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312452 | petrolatum 31.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312452 | petrolatum 31.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312453 | petrolatum 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312454 | petrolatum / vitamin E Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312455 | petrolatum / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312456 | petrolatum / vitamin E Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312457 | petrolatum / vitamin E Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312458 | petrolatum / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1312459 | petrolatum 250 MG / vitamin E 10 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312459 | petrolatum 250 MG / vitamin E 10 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312460 | potassium iodide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312461 | ammonium chloride / potassium iodide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312462 | ammonium chloride / potassium iodide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312463 | ammonium chloride / potassium iodide Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312464 | ammonium chloride / potassium iodide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1312465 | NH4Cl 20 MG/ML / K+ Iodide 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312465 | NH4Cl 20 MG/ML / K+ Iodide 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312465 | NH4Cl 20 MG/ML / K+ Iodide 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312466 | Palladia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312467 | toceranib phosphate 15 MG [Palladia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312468 | toceranib Oral Tablet [Palladia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312469 | Palladia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312470 | Palladia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312471 | Palladia 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312471 | Palladia 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312471 | Palladia 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312472 | Lutalyse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312473 | dinoprost 5 MG/ML [Lutalyse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312474 | dinoprost Injectable Solution [Lutalyse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312475 | Lutalyse Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312476 | Lutalyse 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312476 | Lutalyse 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312476 | Lutalyse 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312476 | Lutalyse 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312481 | toceranib phosphate 10 MG [Palladia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312482 | Palladia 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312482 | Palladia 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312482 | Palladia 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312483 | ammonia 45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312484 | ammonia 4.5 % Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312484 | ammonia 4.5 % Nasal Inhalant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312484 | ammonia 4.5 % Nasal Inhalant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312485 | Eucalyptus oil 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312486 | menthol 360 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312487 | methyl salicylate 370 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312488 | camphor / Eucalyptus oil / menthol / methyl salicylate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312489 | camphor 10 % / eucalyptus oil 10 % / menthol 36 % / methyl salicylate 37 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312489 | camphor 10 % / eucalyptus oil 10 % / menthol 36 % / methyl salicylate 37 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312489 | camphor 10 % / eucalyptus oil 10 % / menthol 36 % / methyl salicylate 37 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312490 | ethanol / povidone-iodine Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312491 | povidone-iodine 10 % / ethanol 70 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312491 | povidone-iodine 10 % / ethanol 70 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312491 | povidone-iodine 10 % / ethanol 70 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312492 | BD Persist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312493 | ethanol 0.7 ML/ML / povidone-iodine 100 MG/ML [BD Persist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312494 | ethanol / povidone-iodine Topical Solution [BD Persist] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312495 | BD Persist Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312496 | BD Persist 10 % / 70 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312496 | BD Persist 10 % / 70 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312496 | BD Persist 10 % / 70 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312497 | toceranib phosphate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312498 | toceranib phosphate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312499 | toceranib phosphate 30 MG [Palladia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312500 | toceranib phosphate 30 MG Oral Tablet [Palladia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312500 | toceranib phosphate 30 MG Oral Tablet [Palladia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312502 | vitamin D3 12.5 MCG (500 UNT) in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312502 | vitamin D3 12.5 MCG (500 UNT) in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312502 | vitamin D3 12.5 MCG (500 UNT) in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312502 | vitamin D3 12.5 MCG (500 UNT) in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312537 | alpha-amylcinnamyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312538 | beta-thujaplicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312539 | Aloe vera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312540 | ammonium benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312541 | Aniba rosaeodora wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312542 | Arctium lappa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312543 | behenyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312544 | Bidens bipinnata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312545 | cetearyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312546 | chromium dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312547 | D&C orange no. 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312548 | diacetyl boldine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312549 | diethylenetriamine pentamethylene phosphonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312551 | diethylhexyl maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312556 | dimethoxy di-p-cresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312557 | dipalmitoylethyl hydroxyethylmonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312558 | diphenylsiloxy phenyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312559 | dipropylene glycol caprate-caprylate diester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312560 | distearyl phthalamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312568 | ethyl 2-methylbutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312573 | ethyl acrylate and methyl methacrylate copolymer (2:1; 600000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312574 | ethyl pentanoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312574 | ethyl pentanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312575 | ethylcellulose (7 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312576 | ethylene-vinyl acetate copolymer (19% vinylacetate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312577 | ethylene-vinyl acetate copolymer (40% vinyl acetate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312579 | Filipendula ulmaria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312581 | methylphenidate hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1312582 | methylphenidate Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1312583 | methylphenidate HCl 25 MG in 5 mL 24HR Extended Release Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312583 | methylphenidate HCl 25 MG in 5 mL 24HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312583 | methylphenidate HCl 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312583 | methylphenidate HCl 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312584 | Quillivant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1312585 | methylphenidate hydrochloride 5 MG/ML [Quillivant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1312586 | methylphenidate Extended Release Suspension [Quillivant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1312587 | Quillivant Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1312588 | Quillivant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312589 | Quillivant XR 25 MG in 5 mL 24HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312590 | methylphenidate hydrochloride 5 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312591 | methylphenidate hydrochloride 5 MG/ML Extended Release Suspension [Quillivant] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312591 | methylphenidate hydrochloride 5 MG/ML Extended Release Suspension [Quillivant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312592 | fosveset | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312593 | garden cress sprout extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312598 | hexyldecyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312599 | hexyldecyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312600 | hydrolysed bovine collagen (enzymatic; 2000-5000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312601 | hydrolyzed elastin, bovine, alkaline (1000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312602 | hydroxycitric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312606 | hydroxyethyl cellulose (1500 MPA.S at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1312611 | hydroxyethylpiperazine ethane sulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312614 | Ipomoea mauritiana tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312615 | isodeceth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312616 | isoniacinamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312620 | isopropyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312621 | lauryl aldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312622 | Ligusticum wallichii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312624 | loteprednol etabonate Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1312625 | loteprednol etabonate 0.5 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312625 | loteprednol etabonate 0.5 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312625 | loteprednol etabonate 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312626 | loteprednol etabonate Ophthalmic Gel [Lotemax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1312627 | LOTEMAX 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312627 | LOTEMAX 0.5 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312627 | LOTEMAX 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312627 | LOTEMAX 0.5 % Ophthalmic Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1312645 | papaya juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312646 | PEG-150 pentaerythrityl tetrastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312647 | tribehenin PEG-20 esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131266 | Ebola virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131266 | Ebola virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131266 | Ebola virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312707 | polyethylene glycol 3500 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312708 | dextranase Penicillium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312709 | polistirex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312710 | PEG-12 dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312711 | PEG-3 alpha-linolenamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312712 | PEG-4 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312713 | aspirin 325 MG / caffeine 30 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312713 | aspirin 325 MG / caffeine 30 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312713 | aspirin 325 MG / caffeine 30 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312714 | methyl diisopropyl propionamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312715 | pentadecalactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312716 | pentaerythrityl distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312717 | Phellinus linteus mycelium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312718 | aspirin 650 MG / caffeine 60 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312718 | aspirin 650 MG / caffeine 60 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312718 | aspirin 650 MG / caffeine 60 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312719 | 4-((4,6-bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-bis(1,1-dimethylethyl)-phenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312720 | Phyllostachys reticulata resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312721 | polyethylene glycol 700 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312722 | Palmaria palmata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312722 | Palmaria palmata extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312723 | polyisobutylene (75000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312724 | Tilia cordata wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312727 | PPG-2 methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312728 | Schinus terebinthifolia whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312728 | Schinus terebinthifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312730 | quaternium-14 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312731 | polyethylene glycol 7000000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312732 | Torreya nucifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312736 | polyisobutylene (2300 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312738 | polyethylene glycol 400000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312739 | terpinyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312740 | silanetriol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312741 | neohesperidin dihydrochalcone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312742 | polyacrylamide (1500 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312743 | perfluorooctyl triethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312746 | camphor 1.2 % / menthol 4 % / methyl salicylate 6.3 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312746 | camphor 1.2 % / menthol 4 % / methyl salicylate 6.3 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312746 | camphor 1.2 % / menthol 4 % / methyl salicylate 6.3 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312747 | capsaicin 0.03 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312747 | capsaicin 0.03 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312747 | capsaicin 0.03 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312748 | Truprofen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312749 | carprofen 100 MG [Truprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312750 | carprofen Oral Tablet [Truprofen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312751 | Truprofen Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312752 | Truprofen Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312753 | TruProfen 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312753 | TruProfen 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312753 | TruProfen 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312754 | carprofen 25 MG [Truprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312755 | TruProfen 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312755 | TruProfen 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312755 | TruProfen 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312756 | carprofen 75 MG [Truprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312757 | TruProfen 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312757 | TruProfen 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312757 | TruProfen 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131276 | Ehrlichia canis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131276 | Ehrlichia canis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312782 | diphenhydrAMINE Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312782 | diphenhydrAMINE Oral Powder Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312783 | diphenhydrAMINE Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312783 | diphenhydrAMINE Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1312784 | diphenhydrAMINE HCl 25 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312784 | diphenhydrAMINE HCl 25 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312784 | diphenhydrAMINE HCl 25 MG Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 131279 | Ehrlichia phagocytophila antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131279 | Ehrlichia phagocytophila antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 13128 | 2-acylglycerophosphocholine acyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 13128 | 2-acylglycerophosphocholine acyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 131280 | Ehrlichia species antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131280 | Ehrlichia species antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131294 | Epstein-Barr virus early antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131294 | Epstein-Barr virus early antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312950 | Bromo Seltzer Antacid Pain Reliever | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312954 | Bromo Seltzer Antacid Pain Reliever Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312956 | Eucalyptus oil 38.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312957 | tea tree oil 42.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312958 | Eucalyptus oil / tea tree oil Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312959 | Eucalyptus oil / tea tree oil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1312960 | Eucalyptus oil / tea tree oil Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312961 | Eucalyptus oil / tea tree oil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1312962 | eucalyptus oil 3.86 % / tea tree oil 4.25 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312962 | eucalyptus oil 3.86 % / tea tree oil 4.25 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312962 | eucalyptus oil 3.86 % / tea tree oil 4.25 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312963 | polysaccharide iron complex (as iron) 15 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312963 | polysaccharide iron complex (as iron) 15 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312963 | polysaccharide iron complex (as iron) 15 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312970 | polysaccharide iron complex (as iron) 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312970 | polysaccharide iron complex (as iron) 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1312975 | ammonium stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312976 | cholecalciferol / polysaccharide iron complex Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1312977 | cholecalciferol / polysaccharide iron complex Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1312978 | cholecalciferol / polysaccharide iron complex Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1312979 | cholecalciferol / polysaccharide iron complex | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1312987 | dimethyl palmitamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312993 | Bensal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1312994 | salicylic acid 0.03 MG/MG [Bensal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1312995 | salicylic acid Topical Ointment [Bensal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1312996 | Bensal Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1312997 | Bensal HP 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312997 | Bensal HP 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1312997 | Bensal HP 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312997 | Bensal HP 3 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1313 | Bacteriorhodopsin | Designated preferred name (PT) | NO | |
| RxCUI: 1313 | Bacteriorhodopsin | Full form of descriptor (FN) | NO | |
| RxCUI: 1313043 | caprylic-capric-lauric triglyceride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313045 | Glycyrrhiza glabra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313046 | acetyl octapeptide-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313047 | curdlan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313054 | myristoyl pentapeptide-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313058 | phentermine 11.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313059 | phentermine 11.25 MG / topiramate 69 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313059 | phentermine 11.25 MG / topiramate 69 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313059 | phentermine 11.25 MG / topiramate 69 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 131306 | Follitropin, beta subunit antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131306 | Follitropin, beta subunit antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1313060 | phentermine 11.25 MG / topiramate 69 MG [Qsymia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313061 | Qsymia 11.25 MG / 69 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313062 | phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313063 | phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313063 | phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313064 | Heartshield Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1313065 | ivermectin 0.136 MG / pyrantel 114 MG [Heartshield Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313066 | ivermectin / pyrantel Chewable Tablet [Heartshield Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1313067 | Heartshield Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313068 | Heartshield Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313069 | Heartshield Plus Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313070 | HEARTSHIELD Plus for Dogs ivermectin 136 MCG / 114 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313070 | HEARTSHIELD Plus for Dogs ivermectin 136 MCG / 114 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313070 | HEARTSHIELD Plus for Dogs ivermectin 136 MCG / 114 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313110 | Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1313110 | Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1313111 | phenytoin 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313112 | phenytoin 125 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 1313115 | ivermectin 0.272 MG / pyrantel 227 MG [Heartshield Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313116 | HEARTSHIELD Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313116 | HEARTSHIELD Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313116 | HEARTSHIELD Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313144 | calcium 250 MG Chewable Tablet, as calcium citrate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313144 | calcium 250 MG Chewable Tablet, as calcium citrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313144 | calcium 250 MG Chewable Tablet, as calcium citrate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313171 | nonoxynol-8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313172 | magnesium asparaginate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313173 | N,N-dimethylglycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313174 | potassium asparaginate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313175 | nickel acetate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313176 | nickel acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313177 | PEG-5 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313178 | PPG-15 stearyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313179 | polyoxypropylene (17) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313179 | polyoxypropylene (17) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313180 | reishi mushroom preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313181 | sodium lauroyl aspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313183 | moth bean extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313184 | dihydrogenated tallow phthalic acid amide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313185 | hypromellose acetate succinate 16070722 (3 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313185 | hypromellose acetate succinate 16070722 (3 MPA.S) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313186 | myristoyl-palmitoyl oxostearamide-arachamide mea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313187 | glucamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313188 | cysteine, DL- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313189 | 4-(butoxymethyl)-2-methoxyphenol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313189 | 4-(butoxymethyl)-2-methoxyphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313195 | disodium 2-sulfolaurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1313199 | pentaerythrityl tetracaprylate-tetracaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313217 | chicken liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313218 | Bos taurus cerebelum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313219 | 1-hexadecene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313220 | 2-ethylaminoethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313221 | 2-O-ethyl ascorbic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313222 | acetyl carboxymethyl cocoyl glycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313223 | acetyl triethylhexyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313224 | aluminum chlorohydrex propylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313225 | Artemisia abrotanum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313226 | bis-ethylhexyl hydroxydimethoxy benzylmalonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313227 | C30-45 alkyl methicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313228 | calcium aluminosilicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313229 | Cladosiphon okamuranus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313230 | Corydalis yanhusuo tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313231 | denatonium benzoate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1313232 | denatonium benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313233 | pear juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313234 | triheptanoin | Full form of descriptor (FN) | YES | |
| RxCUI: 1313234 | triheptanoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313234 | triheptanoin | Designated preferred name (PT) | YES | |
| RxCUI: 1313234 | triheptanoin | Full form of descriptor (FN) | YES | |
| RxCUI: 1313234 | triheptanoin | Designated preferred name (PT) | YES | |
| RxCUI: 1313236 | Pistacia lentiscus resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313237 | methyl heptine carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313238 | isoamyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313239 | isocetyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313240 | isocetyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313241 | isoeicosane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313242 | Liquidambar styraciflua resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313243 | manganese violet | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313244 | methylserine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313245 | metyrapone tartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313245 | metyrapone tartrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1313246 | myristyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313247 | myristyl propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313248 | o-xylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313249 | povidone K17 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313251 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT [Cotazym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313252 | amylase / lipase / protease Oral Capsule [Cotazym] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1313253 | Cotazym Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313254 | Cotazym Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313255 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Capsule [Cotazym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313255 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Capsule [Cotazym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313255 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Capsule [Cotazym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313256 | PEG-12 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313257 | PEG-12 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313258 | PEG-8 ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313259 | tocopheryl retinoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313260 | octyldodecyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313261 | 4-methyl anisole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313264 | dimethicone PEG-8 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313265 | ethylhexyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313266 | polyethylene glycol 500 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313267 | trideceth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313268 | quadrosilan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313269 | citronellol acetate, (S)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313270 | polyacrylamide (crosslinked; 0.01-0.2 mole percent bisacrylamide) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313271 | rimethylolpropane tricaprylate-tricaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313275 | aconitic acid, (Z)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313277 | sodium benzenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313278 | benzenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313279 | uranyl nitrate hexahydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313280 | magnesium phosphate, tribasic, pentahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313283 | Aspergillus niger immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313294 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313294 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1313295 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Quala HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313295 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML [Quala HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1313296 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution [Quala HC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313296 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution [Quala HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1313296 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution [Quala HC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313296 | guaifenesin 10 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution [Quala HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1313298 | dextromethorphan HBr 30 MG / pseudoephedrine HCl 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313298 | dextromethorphan HBr 30 MG / pseudoephedrine HCl 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313302 | manganese phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313303 | 2,5-piperazinedione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313304 | 3-phytase B (Aspergillus niger) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313305 | 5-hydroxytryptophan, DL- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313308 | Allium cepa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313309 | ammonium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313310 | ammonium cation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313310 | ammonium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313311 | Amoeba proteus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313312 | Anguilla rostrata blood serum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313314 | antimony arsenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313315 | arsenic tribromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313319 | avens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131332 | Gonadotrophin peptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131332 | Gonadotrophin peptide | Designated preferred name (PT) | NO | |
| RxCUI: 131332 | Gonadotrophin peptide | Full form of descriptor (FN) | NO | |
| RxCUI: 1313321 | cupric carbonate basic | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313322 | beef heart preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313328 | BDNF, human | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313328 | BDNF, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313334 | Coniine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313334 | Coniine | Designated preferred name (PT) | NO | |
| RxCUI: 1313334 | Coniine | Full form of descriptor (FN) | NO | |
| RxCUI: 1313336 | dichromate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313337 | dodecahydroxycyclohexane dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313342 | Fagus sylvatica nut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313343 | fluorapatite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313349 | dimethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131358 | Hemoglobin antigen | British preferred term (PTGB) | NO | |
| RxCUI: 131358 | Hemoglobin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131358 | Hemoglobin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1313642 | amylases 16,600 UNT / endopeptidases 18,800 UNT / lipase 5000 UNT Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313642 | amylases 16,600 UNT / endopeptidases 18,800 UNT / lipase 5000 UNT Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313642 | amylases 16,600 UNT / endopeptidases 18,800 UNT / lipase 5000 UNT Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313685 | Stevia rebaudiana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313686 | Saponaria officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313687 | Eleutherococcus sessilflorus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313688 | Moschus moschiferus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313689 | Solidago canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131369 | Hexaporphyrin | Designated preferred name (PT) | NO | |
| RxCUI: 131369 | Hexaporphyrin | Full form of descriptor (FN) | NO | |
| RxCUI: 131369 | Hexaporphyrin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313690 | Eupatorium japonicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313691 | Nasturtium officienale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Designated preferred name (PT) | NO | |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Full form of descriptor (FN) | NO | |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313692 | Capsicum annuum var. annuum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313693 | sodium myristoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313695 | sodium palmitoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313697 | ethylcellulose (20 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313698 | ethylcellulose (4 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313699 | methylcellulose (15 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313699 | methylcellulose (15 MPA.S) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313700 | methylcellulose (1500 CPS) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313701 | methylcellulose (25 CPS) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313702 | methylcellulose (400 cps) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313703 | cetyl hydroxyethylcellulose (350000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313704 | ethylcellulose (10 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313705 | dodecyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313706 | hexyl decanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313707 | 3,7-dimethyloctane-1,7-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313709 | hydrogenated palm kernel glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313710 | ethylene-vinyl acetate copolymer (15% vinyl acetate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313711 | poloxamer 335 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313712 | hydrolyzed glycosaminoglycans (bovine; 50000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313716 | disodium glycyrrhizate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313718 | povidone k25-28 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313719 | polyacrylamide (10000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313720 | methicone (20 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313721 | polyglycerin-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313722 | regrelor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313723 | Phenoxyisopropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313723 | Phenoxyisopropanol | Designated preferred name (PT) | YES | |
| RxCUI: 1313723 | Phenoxyisopropanol | Full form of descriptor (FN) | YES | |
| RxCUI: 1313724 | phenylethyl resorcinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313725 | polybutene (1400 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313731 | 1-eicosene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313732 | 2-ethylhexyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313733 | dimethylhydroxy furanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313733 | dimethylhydroxy furanone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313734 | Arisaema dracontium root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313735 | beheneth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313736 | C12-14 pareth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313737 | D&C brown no. 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313738 | decyloxazolidinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313739 | diethylene glycol adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313740 | diethylhexyl succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313741 | diglycerin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313742 | dimethicone PEG-7 isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313743 | dimethyl lauramine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313746 | dipentaerythrityl hexahydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313747 | Ericerus pela polycosanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313748 | ethyl levulinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313749 | ethylhexyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313750 | Geranium robertianum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313759 | zinc pyrithione 5.28 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 131376 | Histoplasma capsulatum mycelial antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131376 | Histoplasma capsulatum mycelial antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313760 | zinc pyrithione 0.528 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313760 | zinc pyrithione 0.528 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313760 | zinc pyrithione 0.528 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313761 | yttrium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313762 | yttrium fluoride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313763 | yttrium iodide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313764 | annatto extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131377 | Histoplasma capsulatum yeast antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131377 | Histoplasma capsulatum yeast antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313770 | Butyl acrylate | Designated preferred name (PT) | NO | |
| RxCUI: 1313770 | Butyl acrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1313770 | Butyl acrylate | Designated preferred name (PT) | NO | |
| RxCUI: 1313770 | Butyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313770 | Butyl acrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1313771 | triethanolamine dodecylbenzenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313771 | triethanolamine dodecylbenzenesulfonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313779 | cysteamine 4.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 131378 | HIV 1 gp120 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131378 | HIV 1 gp120 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131378 | HIV 1 gp120 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313780 | cysteamine HCl 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313780 | cysteamine HCl 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313780 | cysteamine HCl 0.44 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313780 | cysteamine HCl 0.44 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313781 | Cystaran | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1313782 | cysteamine 4.4 MG/ML [Cystaran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1313783 | cysteamine Ophthalmic Solution [Cystaran] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1313784 | Cystaran Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1313785 | cystaran 0.44 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313785 | cystaran 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313785 | cystaran 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313785 | cystaran 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313785 | cystaran 0.44 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 131379 | HIV 1 gp160 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131379 | HIV 1 gp160 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131379 | HIV 1 gp160 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131380 | HIV 1 gp41 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131380 | HIV 1 gp41 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131380 | HIV 1 gp41 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131381 | HIV 1 p17 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131381 | HIV 1 p17 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131381 | HIV 1 p17 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313812 | GRX Hemorrhoidal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1313814 | mineral oil / petrolatum / phenylephrine Rectal Ointment [GRX Hemorrhoidal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1313815 | GRX Hemorrhoidal Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313818 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313818 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313818 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313819 | mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG [GRX Hemorrhoidal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313820 | GRX Hemorrhoidal 14 % / 71.9 % / 0.25 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313820 | GRX Hemorrhoidal 14 % / 71.9 % / 0.25 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313820 | GRX Hemorrhoidal 14 % / 71.9 % / 0.25 % Rectal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313822 | menthol 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313823 | menthol 4.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313823 | menthol 4.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313823 | menthol 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313825 | flunisolide 0.025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 131383 | Antigen of Human immunodeficiency virus 1 protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131383 | Antigen of Human immunodeficiency virus 1 protein 24 | Full form of descriptor (FN) | NO | |
| RxCUI: 131383 | Antigen of Human immunodeficiency virus 1 protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131383 | Antigen of Human immunodeficiency virus 1 protein 24 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131383 | Antigen of Human immunodeficiency virus 1 protein 24 | Designated preferred name (PT) | NO | |
| RxCUI: 1313830 | Bacillus coagulans 50000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 131384 | HIV 1 p31 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131384 | HIV 1 p31 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131384 | HIV 1 p31 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313847 | Lactobacillus rhamnosus GG 2.5 Billion UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313847 | Lactobacillus rhamnosus GG 2.5 Billion UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313847 | Lactobacillus rhamnosus GG 2.5 Billion UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131385 | HIV 1 p51 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131385 | HIV 1 p51 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131385 | HIV 1 p51 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131386 | HIV 1 p55 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131386 | HIV 1 p55 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131386 | HIV 1 p55 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131387 | HIV 1 p66 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131387 | HIV 1 p66 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131387 | HIV 1 p66 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1313878 | Nasadrops | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1313880 | sodium chloride Nasal Solution [Nasadrops] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1313881 | Nasadrops Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313882 | sodium chloride 9 MG/ML Nasal Solution [Nasadrops] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313882 | sodium chloride 9 MG/ML Nasal Solution [Nasadrops] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313882 | sodium chloride 9 MG/ML Nasal Solution [Nasadrops] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313882 | sodium chloride 9 MG/ML Nasal Solution [Nasadrops] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313883 | phenytoin 25 MG/ML [Dilantin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313884 | Dilantin-125, 125 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1313885 | phenytoin 50 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1313886 | phenytoin 50 MG [Dilantin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1313887 | Dilantin INFATABS 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313887 | Dilantin INFATABS 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313887 | Dilantin INFATABS 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313887 | Dilantin INFATABS 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313887 | Dilantin INFATABS 50 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1313888 | phenytoin 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313888 | phenytoin 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313888 | phenytoin 30 MG per 5 ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1313888 | phenytoin 30 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313888 | phenytoin 30 MG per 5 ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1313889 | phenytoin 18 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1313890 | phenytoin 90 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313890 | phenytoin 90 MG per 5 ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1313890 | phenytoin 90 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313890 | phenytoin 90 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313890 | phenytoin 90 MG per 5 ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1313909 | Sinufrin Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1313910 | oxymetazoline hydrochloride 0.5 MG/ML [Sinufrin Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313911 | oxymetazoline Nasal Spray [Sinufrin Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1313912 | Sinufrin Plus Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313913 | Sinufrin Plus Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1313914 | Sinufrin Plus 12 Hour Decongestant 0.05 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313914 | Sinufrin Plus 12 Hour Decongestant 0.05 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313914 | Sinufrin Plus 12 Hour Decongestant 0.05 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313914 | Sinufrin Plus 12 Hour Decongestant 0.05 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313919 | docusate sodium 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313920 | zinc oxide 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313921 | alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1313922 | alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1313923 | alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1313924 | alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313925 | alpha-tocopherol acetate 30 UNT / vit-C 100 MG / beta carotene 1000 UNT / calcium carbonate 200 MG / calcium pantothenate 7 MG / cholecalciferol 400 UNT / DOSS sodium 25 MG / ferrous fumarate 29 MG / folate 1 MG / niacinamide 15 MG / vit-B6 hydrochloride 20 MG / riboflavin 3 MG / vit-B1 3 MG / vitamin B12 0.012 MG / ZNO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313926 | polysaccharide iron complex 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313927 | polysaccharide iron complex (as iron) 125 MG / cholecalciferol 100 UNT in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313927 | polysaccharide iron complex (as iron) 125 MG / cholecalciferol 100 UNT in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313927 | polysaccharide iron complex (as iron) 125 MG / cholecalciferol 100 UNT in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313927 | polysaccharide iron complex (as iron) 125 MG / cholecalciferol 100 UNT in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313953 | chromium picolinate / cinnamon bark Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1313954 | chromium picolinate / cinnamon bark Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1313955 | chromium picolinate / cinnamon bark Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1313956 | chromium picolinate / cinnamon bark | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1313957 | cinnamon bark 500 MG / chromium picolinate 100 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313957 | cinnamon bark 500 MG / chromium picolinate 100 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313960 | Cladosporium herbarum allergenic extract 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1313961 | Cladosporium herbarum allergenic extract 10000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313966 | 5-methyltetrahydrofolic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313968 | polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine-N-butyl methacrylate; 4:1) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313969 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313969 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313969 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313970 | ivermectin 0.068 MG / pyrantel 57 MG [Heartshield Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1313971 | HEARTSHIELD Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1313971 | HEARTSHIELD Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1313971 | HEARTSHIELD Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1313972 | Mucor racemosus immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313973 | Viscum album whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313974 | monosodium glutamate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313975 | zinc myristate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313976 | myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313977 | stearamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313978 | stearyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1313979 | stearyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1313980 | magnesium myristate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1313984 | magnesium citrate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1313985 | magnesium citrate 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1313985 | magnesium citrate 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1313985 | magnesium citrate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1313986 | magnesium sulfate 0.417 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1313987 | magnesium sulfate 5 GM per 100 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1313987 | magnesium sulfate 5 GM per 100 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131400 | Hydroxybupropion | Designated preferred name (PT) | NO | |
| RxCUI: 131400 | Hydroxybupropion | Full form of descriptor (FN) | NO | |
| RxCUI: 1314132 | ondansetron Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1314133 | ondansetron 4 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314133 | ondansetron 4 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314133 | ondansetron 4 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1314134 | lidocaine / phenylephrine Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314135 | lidocaine / phenylephrine Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1314136 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314136 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314136 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314137 | Hemaway | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314138 | lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML [Hemaway] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314139 | lidocaine / phenylephrine Rectal Cream [Hemaway] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314140 | Hemaway Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314141 | HemAway 5 % / 0.25 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314141 | HemAway 5 % / 0.25 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314141 | HemAway 5 % / 0.25 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314143 | witch hazel 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314144 | witch hazel 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314144 | witch hazel 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314144 | witch hazel 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314190 | PEG-20 soy sterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314191 | PEG-200 dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314192 | PEG-25 propylene glycol stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314193 | PEG-6 methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314194 | PEG-8 dimethicone (600 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314194 | PEG-8 dimethicone (600 CST) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314195 | immunoglobulin M, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314196 | pentaerythrityl tetraoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314197 | Phellinus linteus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314198 | mutanase Schizosaccharomyces pombe | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314199 | Piper methysticum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314200 | polyester-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314201 | polyester-8 (1400 MW, cyanodiphenylpropenoyl capped) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314202 | polyethylene oxide 1000000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314202 | polyethylene oxide 1000000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314203 | polyethylene glycol 600000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314204 | polyethylene glycol 900 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314205 | polyglycerin-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314206 | polyisobutylene (35000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314207 | kojic dipalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314208 | octyldodecyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314209 | PPG-2 isoceteth-20 acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314210 | PPG-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314211 | lauryl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314212 | propylene glycol dibenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314213 | sodium chondroitin sulfate (porcine; 5500 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314214 | Chondroitin sulfate A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314214 | Chondroitin sulfate A | Designated preferred name (PT) | NO | |
| RxCUI: 1314214 | Chondroitin sulfate A | Full form of descriptor (FN) | NO | |
| RxCUI: 1314214 | Chondroitin sulfate A | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314215 | trolamine stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314216 | nonoxynol-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314217 | myristalkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1314219 | laponite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314220 | magnesium tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1314221 | tartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314222 | Taxus baccata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314223 | methyl sorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314224 | Santalum album seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314225 | 1-tetradecene | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314225 | 1-tetradecene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314226 | Syringa vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314227 | hydroxytyrosol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314228 | Musa basjoo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314229 | tetrapropyl orthosilicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314230 | PEG-4 diheptanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314231 | pyridoxine dipalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314232 | undecylenic acid monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314233 | prezatide copper | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314234 | polyquaternium 37 (200 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314235 | isopulegol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314236 | Ferula ammoniacum resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314236 | Ferula ammoniacum resin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314237 | bovine bone marrow preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314237 | bovine bone marrow preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314238 | Vaccinium vitis-idaea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314239 | propylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314240 | interferon gamma-1a | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314241 | glycereth-17 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314242 | Amylobarbitone sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314242 | Amylobarbitone sodium | Designated preferred name (PT) | YES | |
| RxCUI: 1314242 | Amylobarbitone sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 1314242 | Amylobarbitone sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314243 | PPG 12 buteth 16 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314244 | Avena sativa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314245 | Lapsana communis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314246 | dimethiconol (100000 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314247 | Phytolacca americana fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314248 | L-lysine monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314248 | L-lysine monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314248 | L-lysine monohydrate | Designated preferred name (PT) | YES | |
| RxCUI: 1314248 | L-lysine monohydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1314249 | xylitylglucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314250 | trimethylsilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314251 | povidone K15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314253 | nonanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314255 | hesperetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314256 | herring sperm DNA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314257 | Juniperus virginiana twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314258 | (2-carbethoxyethyl)diethoxy(methyl)silane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314259 | 1-tetracosanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131426 | Anti-bovine insulin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131426 | Anti-bovine insulin antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131426 | Anti-bovine insulin antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1314260 | 3-((L-menthyl)oxy)propane-1,2-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314261 | 4-carvomenthenol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314261 | 4-carvomenthenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314262 | Achyranthes japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314265 | Arabidopsis thaliana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314265 | Arabidopsis thaliana whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314266 | arachidyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314267 | Asclepias quadrifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314268 | ascorbyl methylsilanol pectinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314269 | bis-PEG-18 methyl ether dimethyl silane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131427 | Anti-human insulin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131427 | Anti-human insulin antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131427 | Anti-human insulin antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1314270 | luffa aegyptiaca seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314271 | n-dodecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314272 | isoamyl butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314273 | N-acetyl dipeptide-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314274 | stannous 2-ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314275 | thioredoxin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314276 | isopentyldiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314277 | palmitoyl tetrapeptide-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314278 | saccharide isomerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314279 | hydroxide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314281 | hexamethylindanopyran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314282 | polyacrylic acid (450000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314283 | stannous cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314284 | palmitoyl tripeptide-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314285 | stearic diethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314286 | stearyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314287 | hydrogenated polybutene (1300 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314288 | PEG-10 soy sterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314289 | quaternium-15 cis-form | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314290 | dimethiconol (250000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314291 | magnesium aluminometasilicate type ib | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314291 | magnesium aluminometasilicate type ib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314292 | trihydroxypalmitamidohydroxypropyl myristyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314293 | trimethoxycaprylylsilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314294 | trimethylolpropane tricaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314295 | trimethylolpropane triethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314296 | tetrapeptide-21 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314297 | polyquaternium-7 (70-30 acrylamide-DADMAC; 900 kD) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314299 | garden lady's mantle extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131430 | Interleukin 2 receptor, soluble | Designated preferred name (PT) | NO | |
| RxCUI: 131430 | Interleukin 2 receptor, soluble | Full form of descriptor (FN) | NO | |
| RxCUI: 1314300 | oleth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314301 | Ulva compressa protein (acid hydrolyzed, 300-5000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314302 | Siberian larch wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314302 | Siberian larch wood extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314303 | propylene glycol, (R)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314304 | dimethyl capramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314305 | trideceth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314306 | ethylhexyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314307 | ceramide AP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314307 | ceramide AP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314308 | methylsilanol ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314309 | Ocimum basilicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314310 | fulvic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314311 | Halimeda opuntia extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314312 | glycol oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314313 | Sisymbrium officianale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314314 | PPG-3 benzyl ether myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314315 | dimethyl benzyl carbinyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314316 | methyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314317 | PPG-14 palmeth-60 hexyl dicarbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314318 | Selaginella tamariscina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314318 | Selaginella tamariscina whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314319 | Bosutinib monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314319 | Bosutinib monohydrate | Designated preferred name (PT) | YES | |
| RxCUI: 1314319 | Bosutinib monohydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1314320 | oregano leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314321 | Caulophyllum robustum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314322 | Kjellmaniella gyrata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314323 | Buddleja davidii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314324 | polyquaternium-7 (76-24 acrylamide-dadmac; 120 kD) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314328 | 2-hydroxyethyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314328 | 2-hydroxyethyl acrylate | Designated preferred name (PT) | YES | |
| RxCUI: 1314328 | 2-hydroxyethyl acrylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1314328 | 2-hydroxyethyl acrylate | Designated preferred name (PT) | YES | |
| RxCUI: 1314328 | 2-hydroxyethyl acrylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1314329 | acetyl hexapeptide-8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314330 | Cyclic AMP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314330 | Cyclic AMP | Designated preferred name (PT) | YES | |
| RxCUI: 1314330 | Cyclic AMP | Full form of descriptor (FN) | YES | |
| RxCUI: 1314330 | Cyclic AMP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314330 | Cyclic AMP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314332 | Bambusa vulgaris top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314333 | behentrimonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314334 | Benzaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314334 | Benzaldehyde | Designated preferred name (PT) | YES | |
| RxCUI: 1314334 | Benzaldehyde | Full form of descriptor (FN) | YES | |
| RxCUI: 1314334 | Benzaldehyde | Designated preferred name (PT) | YES | |
| RxCUI: 1314334 | Benzaldehyde | Full form of descriptor (FN) | YES | |
| RxCUI: 1314335 | C12-14 isoparaffin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314336 | C13-15 alkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314337 | C13-16 isoparaffin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314339 | Carbadox | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314339 | Carbadox | Designated preferred name (PT) | NO | |
| RxCUI: 1314339 | Carbadox | Full form of descriptor (FN) | NO | |
| RxCUI: 1314340 | cetearyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314341 | ceteth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314342 | ceteth-10 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314343 | cetyl myristoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314344 | Coenzyme A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314344 | Coenzyme A | Designated preferred name (PT) | NO | |
| RxCUI: 1314344 | Coenzyme A | Full form of descriptor (FN) | NO | |
| RxCUI: 1314345 | Decoquinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314345 | Decoquinate | Designated preferred name (PT) | YES | |
| RxCUI: 1314345 | Decoquinate | Full form of descriptor (FN) | YES | |
| RxCUI: 1314346 | dihexadecyl hydrogen phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314346 | dihexadecyl hydrogen phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314347 | diosmetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314348 | dipropylene glycol dibenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314349 | edetol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314350 | ergothioneine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314351 | Aesculin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314351 | Aesculin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314351 | Aesculin | Designated preferred name (PT) | NO | |
| RxCUI: 1314351 | Aesculin | Full form of descriptor (FN) | NO | |
| RxCUI: 1314351 | Aesculin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314352 | ethanethiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314353 | Ethopabate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314353 | Ethopabate | Designated preferred name (PT) | NO | |
| RxCUI: 1314353 | Ethopabate | Full form of descriptor (FN) | NO | |
| RxCUI: 1314354 | Ethoxyquin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314354 | Ethoxyquin | Designated preferred name (PT) | NO | |
| RxCUI: 1314354 | Ethoxyquin | Full form of descriptor (FN) | NO | |
| RxCUI: 1314355 | ethyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314356 | ethyl butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314357 | ethyl isovalerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314358 | ethyl macadamiate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314359 | ethyl maltol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131436 | Junin virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131436 | Junin virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1314360 | ethyl nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314361 | ethyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314362 | Ethene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314362 | Ethene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314362 | Ethene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314362 | Ethene | Designated preferred name (PT) | NO | |
| RxCUI: 1314362 | Ethene | Full form of descriptor (FN) | NO | |
| RxCUI: 1314362 | Ethene | Designated preferred name (PT) | NO | |
| RxCUI: 1314362 | Ethene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314362 | Ethene | Full form of descriptor (FN) | NO | |
| RxCUI: 1314363 | ethylene brassylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314364 | ethylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314365 | 2-ethoxyethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314366 | manganese carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314367 | palmatine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314368 | Medronic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314368 | Medronic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1314368 | Medronic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1314370 | narasin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314370 | narasin | Designated preferred name (PT) | NO | |
| RxCUI: 1314370 | narasin | Full form of descriptor (FN) | NO | |
| RxCUI: 1314371 | fanolesomab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314372 | Indium (111-In) oxine | Designated preferred name (PT) | YES | |
| RxCUI: 1314372 | Indium (111-In) oxine | Full form of descriptor (FN) | YES | |
| RxCUI: 1314372 | Indium (111-In) oxine | Designated preferred name (PT) | YES | |
| RxCUI: 1314372 | Indium (111-In) oxine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1314372 | Indium (111-In) oxine | Full form of descriptor (FN) | YES | |
| RxCUI: 1314373 | palmitoyl oligopeptide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314374 | oleth-3-phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314375 | oleth-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314376 | polacrilin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314377 | polacrillin potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1314379 | poloxamer 124 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314380 | poloxamer 182 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314381 | polyaminopropyl biguanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314381 | polyaminopropyl biguanide | Designated preferred name (PT) | YES | |
| RxCUI: 1314381 | polyaminopropyl biguanide | Full form of descriptor (FN) | YES | |
| RxCUI: 1314382 | polyethylene glycol 1600 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314382 | polyethylene glycol 1600 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314384 | polyethylene glycol 6000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314385 | semduramicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314386 | pseudopterogorgia elisabethae extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314393 | niacinamide 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314394 | pyridoxine hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314395 | thiamine hydrochloride 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314396 | dexpanthenol / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1314397 | dexpanthenol / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1314398 | dexpanthenol / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314399 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vitamin B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vit-B1 hydrochloride 12.5 MG/ML / vitamin B12 0.005 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314400 | guaiFENesin 500 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314400 | guaiFENesin 500 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314400 | guaiFENesin 500 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314403 | guaifenesin 500 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314403 | guaifenesin 500 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314405 | rabbit skin extract 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314406 | rabbit skin extract 10,000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314406 | rabbit skin extract 10,000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314409 | Racemic lactic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314409 | Racemic lactic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314409 | Racemic lactic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314410 | germanium sesquioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314411 | propylene glycol monostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314412 | Flavin adenine dinucleotide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314412 | Flavin adenine dinucleotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314412 | Flavin adenine dinucleotide | Designated preferred name (PT) | NO | |
| RxCUI: 1314412 | Flavin adenine dinucleotide | Full form of descriptor (FN) | NO | |
| RxCUI: 1314413 | roxarsone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314414 | poloxalene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314415 | isopropyl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314416 | L-methamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314416 | L-methamphetamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314416 | L-methamphetamine | Designated preferred name (PT) | NO | |
| RxCUI: 1314416 | L-methamphetamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1314416 | L-methamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314417 | tributyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314418 | tributyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314419 | tricaprin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314420 | glycerol tricaprylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314420 | glycerol tricaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314421 | tricaprylyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314423 | zein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314424 | fu ling | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314460 | Chinese elm pollen extract 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314461 | Chinese elm pollen extract 10000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314461 | Chinese elm pollen extract 10000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314461 | Chinese elm pollen extract 10000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314462 | epsiprantel 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314463 | epsiprantel 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314463 | epsiprantel 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314464 | epsiprantel 12.5 MG [Cestex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314465 | Cestex 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314465 | Cestex 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314465 | Cestex 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314466 | epsiprantel 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314467 | epsiprantel 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314467 | epsiprantel 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314468 | epsiprantel 25 MG [Cestex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314469 | Cestex 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314469 | Cestex 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314469 | Cestex 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314470 | epsiprantel 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314471 | epsiprantel 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314471 | epsiprantel 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314472 | epsiprantel 50 MG [Cestex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314473 | Cestex 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314473 | Cestex 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314473 | Cestex 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314474 | miconazole nitrate 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314474 | miconazole nitrate 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314474 | miconazole nitrate 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314475 | Solv X | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314476 | salicylic acid 18 MG/ML [Solv X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314477 | salicylic acid Medicated Shampoo [Solv X] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314478 | Solv X Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314479 | SOLV-X 1.8 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314479 | SOLV-X 1.8 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314479 | SOLV-X 1.8 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314479 | SOLV-X 1.8 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314488 | poloxalene 833 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314489 | poloxalene Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1314490 | poloxalene Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1314491 | poloxalene Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1314492 | poloxalene 833 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314493 | Therabloat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314494 | poloxalene 833 MG/ML [Therabloat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314495 | poloxalene Oral Solution [Therabloat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314496 | Therabloat Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314497 | Therabloat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314498 | poloxalene 833 MG/ML Oral Solution [Therabloat] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314498 | poloxalene 833 MG/ML Oral Solution [Therabloat] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314498 | poloxalene 833 MG/ML Oral Solution [Therabloat] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314499 | calcium carbonate 1177 MG (Ca 471 MG) / simethicone 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314499 | calcium carbonate 1177 MG (Ca 471 MG) / simethicone 80 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314499 | calcium carbonate 1177 MG (Ca 471 MG) / simethicone 80 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 131456 | Antigen of Lassa mammarenavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131456 | Antigen of Lassa mammarenavirus | Full form of descriptor (FN) | NO | |
| RxCUI: 131456 | Antigen of Lassa mammarenavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131456 | Antigen of Lassa mammarenavirus | Designated preferred name (PT) | NO | |
| RxCUI: 131456 | Antigen of Lassa mammarenavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314580 | Bitter orange oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314580 | Bitter orange oil | Designated preferred name (PT) | YES | |
| RxCUI: 1314580 | Bitter orange oil | Full form of descriptor (FN) | YES | |
| RxCUI: 1314580 | Bitter orange oil | Designated preferred name (PT) | YES | |
| RxCUI: 1314580 | Bitter orange oil | Full form of descriptor (FN) | YES | |
| RxCUI: 1314581 | Bos taurus peyer's patch preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314582 | Dryopteris crassirhizoma whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314583 | Hydrastis canadensis whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314584 | Uncaria sinensis whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314585 | polyethylene glycol 11000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314586 | Carthamus tinctorius seedcake extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314587 | cardamom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314588 | hydrogenated polydecene type I | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314588 | hydrogenated polydecene type I | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314589 | Tiamulin fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314589 | Tiamulin fumarate | Designated preferred name (PT) | NO | |
| RxCUI: 1314589 | Tiamulin fumarate | Full form of descriptor (FN) | NO | |
| RxCUI: 1314591 | eastern redcedar allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314591 | eastern redcedar allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314592 | Streptomyces griseus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314593 | Ovalbumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314593 | Ovalbumin | Designated preferred name (PT) | NO | |
| RxCUI: 1314593 | Ovalbumin | Full form of descriptor (FN) | NO | |
| RxCUI: 1314594 | lemon peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314595 | Agrimonia eupatoria extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314596 | prezatide copper acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314597 | rosemary extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314612 | Altrenogest | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314612 | Altrenogest | Designated preferred name (PT) | YES | |
| RxCUI: 1314612 | Altrenogest | Full form of descriptor (FN) | YES | |
| RxCUI: 1314612 | Altrenogest | Designated preferred name (PT) | YES | |
| RxCUI: 1314612 | Altrenogest | Full form of descriptor (FN) | YES | |
| RxCUI: 1314613 | altrenogest 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314614 | altrenogest Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1314615 | altrenogest Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1314616 | altrenogest Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1314617 | altrenogest 0.22 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314617 | altrenogest 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314617 | altrenogest 0.22 % Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314618 | Altresyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314619 | altrenogest 2.2 MG/ML [Altresyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314620 | altrenogest Oral Solution [Altresyn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314621 | Altresyn Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314622 | Altresyn Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314623 | altrenogest 2.2 MG/ML Oral Solution [Altresyn] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314623 | altrenogest 2.2 MG/ML Oral Solution [Altresyn] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314624 | pyridoxine hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314625 | thiamine hydrochloride 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314626 | dexpanthenol 10 MG/ML / niacinamide 100 MG/ML / vitamin B6 hydrochloride 10 MG/ML / riboflavin 5 MG/ML / vitamin B1 hydrochloride 100 MG/ML / vitamin B12 0.1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314629 | 2 ML phenylephrine hydrochloride 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314635 | thiamine hydrochloride 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314636 | dexpanthenol 5 MG/ML / niacinamide 12.5 MG/ML / vit-B6 hydrochloride 5 MG/ML / riboflavin 2 MG/ML / vitamin B1 hydrochloride 1.25 MG/ML / vitamin B12 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131465 | Leptospira interrogans antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131465 | Leptospira interrogans antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1314650 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314651 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314652 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1314653 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314654 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 324 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / vit-B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314656 | radish extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314657 | octyl triazone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314657 | octyl triazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314657 | octyl triazone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314658 | ascorbic acid 210 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314659 | ferrous fumarate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314660 | polysaccharide iron complex 92.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314661 | thiamine mononitrate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314662 | ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314663 | ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314664 | ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1314665 | ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314666 | vit-C 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / nicotinic acid 20 MG / polysaccharide iron complex 92.4 MG / vitamin B6 hydrochloride 25 MG / riboflavin 5 MG / vitamin B1 mononitrate 5 MG / vitamin B12 0.01 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314667 | Concept OB | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1314668 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG [Concept OB] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1314669 | ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate Oral Capsule [Concept OB] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1314670 | Concept OB Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314671 | Concept OB Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314672 | ascorbic acid 210 MG / biotin 0.3 MG / calcium pantothenate 7 MG / copper sulfate 0.8 MG / ferrous fumarate 130 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacin 20 MG / polysaccharide iron complex 92.4 MG / pyridoxine hydrochloride 25 MG / riboflavin 5 MG / thiamine mononitrate 5 MG / vitamin B12 0.01 MG / zinc sulfate 18.2 MG Oral Capsule [Concept OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314675 | copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314676 | copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314677 | copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1314678 | copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314679 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314680 | Tandem Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1314681 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG [Tandem Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1314682 | copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Capsule [Tandem Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1314683 | Tandem Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314684 | Tandem Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1314685 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 131474 | Lutropin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131474 | Lutropin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1314762 | tobramycin 75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1314763 | tobramycin 300 MG in 4 ML Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1314763 | tobramycin 300 MG in 4 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314763 | tobramycin 300 MG in 4 ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314764 | Bethkis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1314765 | tobramycin 75 MG/ML [Bethkis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1314767 | Bethkis Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314768 | Bethkis 300 MG per 4 ML Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1314768 | Bethkis 300 MG per 4 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314768 | Bethkis 300 MG per 4 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314768 | Bethkis 300 MG per 4 ML Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1314769 | Carprieve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314770 | carprofen 100 MG [Carprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314771 | carprofen Oral Tablet [Carprieve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314772 | Carprieve Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314773 | Carprieve Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314774 | Carprieve 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314774 | Carprieve 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314774 | Carprieve 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314775 | carprofen 25 MG [Carprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314776 | Carprieve 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314776 | Carprieve 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314776 | Carprieve 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314777 | carprofen 75 MG [Carprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314778 | Carprieve 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314778 | Carprieve 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314778 | Carprieve 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314779 | cocoa butter 85.4 % / phenylephrine HCl 0.25 % Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314779 | cocoa butter 85.4 % / phenylephrine HCl 0.25 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314779 | cocoa butter 85.4 % / phenylephrine HCl 0.25 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314779 | cocoa butter 85.4 % / phenylephrine HCl 0.25 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131478 | Lysozyme antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131478 | Lysozyme antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1314782 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314783 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1314784 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1314785 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314786 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folate 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / vitamin B6 hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / vitamin B1 mononitrate 10 MG / vitamin B12 0.015 MG / ZnSO4 18.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314787 | Tandem OB | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314788 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG [Tandem OB] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314789 | copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate Oral Capsule [Tandem OB] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314790 | Tandem OB Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314791 | Tandem OB Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314792 | calcium pantothenate 10 MG / copper sulfate 0.8 MG / ferrous fumarate 162 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / polysaccharide iron complex 115 MG / pyridoxine hydrochloride 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine mononitrate 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Tandem OB] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314842 | beheneth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314843 | Capsicum annuum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314844 | Corallina officinalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314846 | silver chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314847 | Toxicodendron vernicifluum fruit rind wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314848 | isostearyl neopentanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314849 | PEG-40 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314850 | Digitalis purpurea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314851 | dihydroxypropyltrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1314853 | Elettaria cardamomum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314854 | Hamamelis virginiana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314855 | Mentha arvensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1314856 | methyl aminomethylcyclohexane carboxamide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1314858 | Ribose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314858 | Ribose | Designated preferred name (PT) | NO | |
| RxCUI: 1314858 | Ribose | Full form of descriptor (FN) | NO | |
| RxCUI: 1314865 | Uniferon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314866 | iron-dextran complex 100 MG/ML [Uniferon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314867 | iron-dextran complex Injectable Solution [Uniferon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314868 | Uniferon Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314869 | iron-dextran complex 100 MG/ML Injectable Solution [Uniferon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314869 | iron-dextran complex 100 MG/ML Injectable Solution [Uniferon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314869 | iron-dextran complex 100 MG/ML Injectable Solution [Uniferon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314870 | Murine Dry Eyes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1314872 | polyvinyl alcohol / povidone Ophthalmic Solution [Murine Dry Eyes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1314873 | Murine Dry Eyes Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1314882 | rOPINIRole 3 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314882 | rOPINIRole 3 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314882 | rOPINIRole 3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314882 | rOPINIRole 3 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314882 | rOPINIRole 3 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314883 | ropinirole 3 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314883 | ropinirole 3 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314884 | water 99 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1314884 | water 99 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1314884 | water 99 % Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1314885 | OcuFlush | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314886 | water 990 MG/ML [OcuFlush] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314887 | water Ophthalmic Irrigation Solution [OcuFlush] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314888 | OcuFlush Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314889 | water 990 MG/ML Ophthalmic Irrigation Solution [OcuFlush] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314889 | water 990 MG/ML Ophthalmic Irrigation Solution [OcuFlush] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314889 | water 990 MG/ML Ophthalmic Irrigation Solution [OcuFlush] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314889 | water 990 MG/ML Ophthalmic Irrigation Solution [OcuFlush] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314891 | Latex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314891 | Latex | Designated preferred name (PT) | NO | |
| RxCUI: 1314891 | Latex | Full form of descriptor (FN) | NO | |
| RxCUI: 1314926 | Lycoperdon utriforme fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314927 | prickly Russian thistle | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314927 | prickly Russian thistle | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1314928 | Kera-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314929 | hydrocortisone 10 MG/ML [Kera-HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314930 | hydrocortisone Topical Cream [Kera-HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314931 | Kera-HC Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314932 | Kera-HC 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314932 | Kera-HC 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314932 | Kera-HC 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314932 | Kera-HC 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314933 | iodine Topical Spray [Teat-Glo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314934 | Teat-Glo 1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314934 | Teat-Glo 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314934 | Teat-Glo 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314934 | Teat-Glo 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314935 | menthol 0.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1314935 | menthol 0.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314935 | menthol 0.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1314936 | phenylephrine hydrochloride 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1314972 | Ivarest Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1314973 | benzyl alcohol 0.105 ML/ML / calamine 140 MG/ML / diphenhydramine hydrochloride 20 MG/ML [Ivarest Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1314973 | benzyl alcohol 0.105 ML/ML / calamine 140 MG/ML / diphenhydramine hydrochloride 20 MG/ML [Ivarest Maximum Strength] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314974 | benzyl alcohol / calamine / diphenhydramine Topical Cream [Ivarest Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1314974 | benzyl alcohol / calamine / diphenhydramine Topical Cream [Ivarest Maximum Strength] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314975 | Ivarest Maximum Strength Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1314976 | Ivarest Maximum Strength 14 % / 10.5 % / 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1314976 | Ivarest Maximum Strength 14 % / 10.5 % / 2 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314976 | Ivarest Maximum Strength 14 % / 10.5 % / 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1314976 | Ivarest Maximum Strength 14 % / 10.5 % / 2 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1314976 | Ivarest Maximum Strength 14 % / 10.5 % / 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1315107 | Argeratina aromatica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315108 | arched swimming crab, cooked preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315109 | casein, emmental cultured | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315110 | casein, Lactococcus lactis cultured | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315111 | casein, Lactococcus lactis cultured, aged | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315112 | casein, Lactococcus lactis cultured, Penicillium camemberti cultured, aged | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315113 | cotton fiber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315114 | Dungeness crab, cooked preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315115 | egg extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315116 | eggplant extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315118 | green bell pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315120 | lamb preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315121 | oyster, unspecified preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315122 | serrated swimming crab, cooked preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315123 | snow crab, unspecified preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315124 | white rice extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1315125 | benzophenone-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1315126 | blue crab preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131516 | Myelin basic protein antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131516 | Myelin basic protein antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131517 | Myoglobin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131517 | Myoglobin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131518 | Naegleria fowleri antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131518 | Naegleria fowleri antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1315202 | Ez2go Osmotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1315206 | Ez2go Osmotic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1315207 | ez2go 17 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1315207 | ez2go 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1315207 | ez2go 17 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 131521 | Normethsuximide | Designated preferred name (PT) | NO | |
| RxCUI: 131521 | Normethsuximide | Full form of descriptor (FN) | NO | |
| RxCUI: 1315214 | Jetrea | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1315217 | Jetrea Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 13153 | 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase | Designated preferred name (PT) | NO | |
| RxCUI: 13153 | 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 131538 | Peanut agglutinin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131538 | Peanut agglutinin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131543 | Pentacarboxylporphyrin | Designated preferred name (PT) | NO | |
| RxCUI: 131543 | Pentacarboxylporphyrin | Full form of descriptor (FN) | NO | |
| RxCUI: 131559 | Antibody to pigeon serum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131559 | Antibody to pigeon serum | Full form of descriptor (FN) | NO | |
| RxCUI: 131559 | Antibody to pigeon serum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131559 | Antibody to pigeon serum | Designated preferred name (PT) | NO | |
| RxCUI: 131559 | Antibody to pigeon serum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131566 | Antigen of Plasmodium falciparum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131566 | Antigen of Plasmodium falciparum | Full form of descriptor (FN) | NO | |
| RxCUI: 131566 | Antigen of Plasmodium falciparum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131566 | Antigen of Plasmodium falciparum | Designated preferred name (PT) | NO | |
| RxCUI: 131569 | Antigen of Plasmodium vivax | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131569 | Antigen of Plasmodium vivax | Full form of descriptor (FN) | NO | |
| RxCUI: 131569 | Antigen of Plasmodium vivax | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131569 | Antigen of Plasmodium vivax | Designated preferred name (PT) | NO | |
| RxCUI: 131578 | Prolactin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131578 | Prolactin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131579 | Prostatic acid phosphatase antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131579 | Prostatic acid phosphatase antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131597 | Rheumatoid arthritis nuclear antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131597 | Rheumatoid arthritis nuclear antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1316053 | Entamoeba histolytica | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316054 | Epstein-Barr virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316073 | Proteus vulgaris | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316076 | Shigella dysenteriae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316080 | West Nile virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316091 | antimony trisulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316104 | herpesvirus 5, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316105 | herpesvirus 1, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131616 | Schistosoma japonicum antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131616 | Schistosoma japonicum antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131617 | Schistosoma mansoni antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131617 | Schistosoma mansoni antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131619 | Serotonin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131619 | Serotonin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131621 | Shigella boydii antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131621 | Shigella boydii antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131622 | Shigella dysenteriae antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131622 | Shigella dysenteriae antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131623 | Shigella flexneri antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131623 | Shigella flexneri antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131624 | Shigella sonnei antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131624 | Shigella sonnei antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131631 | Somatostatin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131631 | Somatostatin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131632 | Somatotropin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131632 | Somatotropin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1316425 | Alcaligenes faecalis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1316426 | Bacillus firmus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131645 | Streptococcus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131645 | Streptococcus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131645 | Streptococcus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1316581 | Ca 2+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1316581 | Ca 2+ | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131664 | Synaptophysin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131664 | Synaptophysin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131665 | T lymphocyte antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131665 | T lymphocyte antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131668 | Thermoactinomyces candidus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131668 | Thermoactinomyces candidus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131669 | Thermoactinomyces sacchari antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131669 | Thermoactinomyces sacchari antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131670 | Thermoactinomyces vulgaris antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131670 | Thermoactinomyces vulgaris antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131671 | Thyroglobulin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131671 | Thyroglobulin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131673 | Thyrotropin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131673 | Thyrotropin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131689 | Trypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131689 | Trypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131700 | Vimentin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131700 | Vimentin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1317116 | velafermin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131724 | Japanese encephalitis virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131724 | Japanese encephalitis virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131725 | Ambien | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 131730 | Placental alkaline phosphatase antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131730 | Placental alkaline phosphatase antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1318050 | interleukin-12, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1318231 | Chimaphila umbellata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318231 | Chimaphila umbellata whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1318233 | Pervinca minor whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1318233 | Pervinca minor whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318234 | Xerophyllum asphodeloides extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318235 | comfrey leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1318236 | Achyrocline satureioides extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318237 | Xanthium root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318237 | Xanthium root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13184 | 2-aminoadipate aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 13184 | 2-aminoadipate aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 1318470 | Brucella melitensis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318474 | Chlamydia trachomatis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318475 | Clostridium perfringens | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318479 | herpesvirus 2, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318494 | allylthiourea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318499 | Human leucocyte antigen B51 | Designated preferred name (PT) | NO | |
| RxCUI: 1318499 | Human leucocyte antigen B51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1318499 | Human leucocyte antigen B51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1318499 | Human leucocyte antigen B51 | Full form of descriptor (FN) | NO | |
| RxCUI: 1318501 | Helicobacter pylori | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1318515 | Prunus armeniaca oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1318515 | Prunus armeniaca oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 13188 | 2-aminobenzoyl-CoA monooxygenase/reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13188 | 2-aminobenzoyl-CoA monooxygenase/reductase | Designated preferred name (PT) | NO | |
| RxCUI: 13188 | 2-aminobenzoyl-CoA monooxygenase/reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13188 | 2-aminobenzoyl-CoA monooxygenase/reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 1318915 | potassium ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1319 | Balsam | Designated preferred name (PT) | NO | |
| RxCUI: 1319 | Balsam | Full form of descriptor (FN) | NO | |
| RxCUI: 1319268 | Anthoxanthum odoratum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1319268 | Anthoxanthum odoratum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13196 | (2-aminoethyl) phosphonate aminotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13196 | (2-aminoethyl) phosphonate aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 13196 | (2-aminoethyl) phosphonate aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 1319885 | Juglans nigra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1319885 | Juglans nigra leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1319902 | Quercus alba bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1319902 | Quercus alba bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |